Alteration	O
of	O
a	O
single	O
serine	O
in	O
the	O
basic	B-protein
domain	I-protein
of	O
the	O
Epstein-Barr	B-protein
virus	I-protein
ZEBRA	I-protein
protein	I-protein
separates	O
its	O
functions	O
of	O
transcriptional	O
activation	O
and	O
disruption	O
of	O
latency	O
.	O

The	O
ZEBRA	B-protein
protein	I-protein
from	O
Epstein-Barr	O
virus	O
(	O
EBV	O
)	O
activates	O
a	O
switch	O
from	O
the	O
latent	O
to	O
the	O
lytic	O
expression	O
program	O
of	O
the	O
virus	O
.	O

ZEBRA	B-protein
,	O
a	O
member	O
of	O
the	O
bZIP	B-protein
family	I-protein
of	O
DNA-binding	B-protein
proteins	I-protein
,	O
is	O
a	O
transcriptional	O
activator	O
capable	O
of	O
inducing	O
expression	O
from	O
viral	B-DNA
lytic	I-DNA
cycle	I-DNA
promoters	I-DNA
.	O

It	O
had	O
previously	O
been	O
thought	O
that	O
ZEBRA	B-protein
's	O
capacity	O
to	O
disrupt	O
EBV	O
latency	O
resided	O
primarily	O
in	O
its	O
ability	O
to	O
activate	O
transcription	O
of	O
genes	O
that	O
encode	O
products	O
required	O
for	O
lytic	O
replication	O
.	O

We	O
generated	O
a	O
point	O
mutant	O
of	O
ZEBRA	B-protein
,	O
Z	B-protein
(	I-protein
S186A	I-protein
)	I-protein
,	O
that	O
was	O
not	O
impaired	O
in	O
its	O
ability	O
to	O
activate	O
transcription	O
;	O
however	O
,	O
this	O
mutation	O
abolished	O
its	O
ability	O
to	O
initiate	O
the	O
viral	O
lytic	O
cascade	O
.	O

The	O
mutant	O
,	O
containing	O
a	O
serine-to-alanine	O
substitution	O
in	O
the	O
DNA-binding	B-protein
domain	I-protein
of	O
the	O
protein	O
,	O
bound	O
to	O
several	O
known	O
ZEBRA-binding	B-DNA
sites	I-DNA
and	O
activated	O
transcription	O
from	O
reporters	O
bearing	O
known	O
ZEBRA-responsive	B-DNA
promoters	I-DNA
but	O
did	O
not	O
disrupt	O
latency	O
in	O
EBV-infected	B-cell_line
cell	I-cell_line
lines	I-cell_line
.	O

Therefore	O
,	O
initiation	O
of	O
the	O
EBV	O
lytic	O
cycle	O
by	O
the	O
ZEBRA	B-protein
protein	I-protein
requires	O
a	O
function	O
in	O
addition	O
to	O
transcriptional	O
activation	O
;	O
a	O
change	O
of	O
serine	O
186	O
to	O
alanine	O
in	O
the	O
DNA-binding	B-protein
domain	I-protein
of	O
ZEBRA	B-protein
abolished	O
this	O
additional	O
function	O
and	O
uncovered	O
a	O
new	O
role	O
for	O
the	O
ZEBRA	B-protein
protein	I-protein
in	O
disruption	O
of	O
EBV	O
latency	O
.	O

The	O
additional	O
function	O
that	O
is	O
required	O
for	O
initiation	O
of	O
the	O
lytic	O
viral	O
life	O
cycle	O
is	O
likely	O
to	O
require	O
phosphorylation	O
of	O
serine	O
186	O
of	O
the	O
ZEBRA	B-protein
protein	I-protein
,	O
which	O
may	O
influence	O
either	O
DNA	O
recognition	O
or	O
transcriptional	O
activation	O
of	O
lytic	B-DNA
viral	I-DNA
promoters	I-DNA
in	O
a	O
chromatinized	B-DNA
viral	I-DNA
episome	I-DNA
.	O

JOURNAL	NULL
OF	NULL
ViroLoGY	NULL
,	NULL
Apr	NULL
.	NULL

1997	NULL
,	NULL
p.	NULL
3054-3061	NULL
0022-538X	NULL
,	NULL
/97/	NULL
$	NULL
04.00+0	NULL
Copyright	NULL
Â©	NULL
1997	NULL
,	NULL
American	NULL
Society	NULL
for	NULL
Microbiology	NULL
Vol	NULL
.	NULL

71	NULL
,	NULL
No	NULL
.	NULL

4	NULL
Alteration	NULL
of	NULL
a	NULL
Single	NULL
Serine	NULL
in	NULL
the	NULL
Basic	NULL
Domain	NULL
of	NULL
the	NULL
Epstein-Barr	NULL
Virus	NULL
ZEBRA	NULL
Protein	NULL
Separates	NULL
Its	NULL
Functions	NULL
of	NULL
Transcriptional	NULL
Activation	NULL
and	NULL
Disruption	NULL
of	NULL
Latency	NULL
AMY	NULL
L.	NULL
FRANCIS	NULL
,	NULL
``	NULL
LYN	NULL
GRADOVILLE	NULL
,	NULL
``	NULL
anp	NULL
GEORGE	NULL
MILLER**	NULL
>	NULL
*	NULL
Department	NULL
of	NULL
Molecular	NULL
Biophysics	NULL
and	NULL
Biochemistry	NULL
,	NULL
Department	NULL
of	NULL
Pediatrics	NULL
,	NULL
``	NULL
and	NULL
Department	NULL
of	NULL
Epidemiology	NULL
and	NULL
Public	NULL
Health	NULL
,	NULL
``	NULL
Yale	NULL
University	NULL
,	NULL
New	NULL
Haven	NULL
,	NULL
Connecticut	NULL
06510	NULL
Received	NULL
28	NULL
October	NULL
1996/Accepted	NULL
26	NULL
December	NULL
1996	NULL
The	NULL
ZEBRA	NULL
protein	NULL
from	NULL
Epstein-Barr	NULL
virus	NULL
(	NULL
EBV	NULL
)	NULL
activates	NULL
a	NULL
switch	NULL
from	NULL
the	NULL
latent	NULL
to	NULL
the	NULL
lytic	NULL
expression	NULL
program	NULL
of	NULL
the	NULL
virus	NULL
.	NULL

ZEBRA	NULL
,	NULL
a	NULL
member	NULL
of	NULL
the	NULL
bZIP	NULL
family	NULL
of	NULL
DNA-binding	NULL
proteins	NULL
,	NULL
is	NULL
a	NULL
transcriptional	NULL
activator	NULL
capable	NULL
of	NULL
inducing	NULL
expression	NULL
from	NULL
viral	NULL
lytic	NULL
cycle	NULL
promoters	NULL
.	NULL

It	NULL
had	NULL
previously	NULL
been	NULL
thought	NULL
that	NULL
ZEBRA	NULL
's	NULL
capacity	NULL
to	NULL
disrupt	NULL
EBV	NULL
latency	NULL
resided	NULL
primarily	NULL
in	NULL
its	NULL
ability	NULL
to	NULL
activate	NULL
transcription	NULL
of	NULL
genes	NULL
that	NULL
encode	NULL
products	NULL
required	NULL
for	NULL
lytic	NULL
replication	NULL
.	NULL

We	NULL
generated	NULL
a	NULL
point	NULL
mutant	NULL
of	NULL
ZEBRA	NULL
,	NULL
Z	NULL
(	NULL
S186A	NULL
)	NULL
,	NULL
that	NULL
was	NULL
not	NULL
impaired	NULL
in	NULL
its	NULL
ability	NULL
to	NULL
activate	NULL
transcription	NULL
;	NULL
however	NULL
,	NULL
this	NULL
mutation	NULL
abolished	NULL
its	NULL
ability	NULL
to	NULL
initiate	NULL
the	NULL
viral	NULL
lytic	NULL
cascade	NULL
.	NULL

The	NULL
mutant	NULL
,	NULL
containing	NULL
a	NULL
serine-to-alanine	NULL
substitution	NULL
in	NULL
the	NULL
DNA-binding	NULL
domain	NULL
of	NULL
the	NULL
protein	NULL
,	NULL
bound	NULL
to	NULL
several	NULL
known	NULL
ZEBRA-binding	NULL
sites	NULL
and	NULL
activated	NULL
transcription	NULL
from	NULL
reporters	NULL
bearing	NULL
known	NULL
ZEBRA-responsive	NULL
promoters	NULL
but	NULL
did	NULL
not	NULL
disrupt	NULL
latency	NULL
in	NULL
EBV-infected	NULL
cell	NULL
lines	NULL
.	NULL

Therefore	NULL
,	NULL
initiation	NULL
of	NULL
the	NULL
EBV	NULL
lytic	NULL
cycle	NULL
by	NULL
the	NULL
ZEBRA	NULL
protein	NULL
requires	NULL
a	NULL
function	NULL
in	NULL
addition	NULL
to	NULL
transcriptional	NULL
activation	NULL
;	NULL
a	NULL
change	NULL
of	NULL
serine	NULL
186	NULL
to	NULL
alanine	NULL
in	NULL
the	NULL
DNA-binding	NULL
domain	NULL
of	NULL
ZEBRA	NULL
abolished	NULL
this	NULL
additional	NULL
function	NULL
and	NULL
uncovered	NULL
a	NULL
new	NULL
role	NULL
for	NULL
the	NULL
ZEBRA	NULL
protein	NULL
in	NULL
disruption	NULL
of	NULL
EBV	NULL
latency	NULL
.	NULL

The	NULL
additional	NULL
function	NULL
that	NULL
is	NULL
required	NULL
for	NULL
initiation	NULL
of	NULL
the	NULL
lytic	NULL
viral	NULL
life	NULL
cycle	NULL
is	NULL
likely	NULL
to	NULL
require	NULL
phosphorylation	NULL
of	NULL
serine	NULL
186	NULL
of	NULL
the	NULL
ZEBRA	NULL
protein	NULL
,	NULL
which	NULL
may	NULL
influence	NULL
either	NULL
DNA	NULL
recognition	NULL
or	NULL
transcriptional	NULL
activation	NULL
of	NULL
lytic	NULL
viral	NULL
promoters	NULL
in	NULL
a	NULL
chromatinized	NULL
viral	NULL
episome	NULL
.	NULL

The	NULL
two	NULL
phases	NULL
in	NULL
the	NULL
life	NULL
cycle	NULL
of	NULL
a	NULL
herpesvirus	NULL
consist	NULL
of	NULL
latency	NULL
,	NULL
during	NULL
which	NULL
only	NULL
a	NULL
few	NULL
viral	NULL
genes	NULL
are	NULL
expressed	NULL
,	NULL
and	NULL
lytic	NULL
replication	NULL
,	NULL
during	NULL
which	NULL
many	NULL
genes	NULL
required	NULL
for	NULL
virus	NULL
maturation	NULL
are	NULL
induced	NULL
.	NULL

Epstein-Barr	NULL
virus	NULL
(	NULL
EBV	NULL
)	NULL
,	NULL
a	NULL
gamma-herpesvirus	NULL
,	NULL
remains	NULL
latent	NULL
in	NULL
B	NULL
lymphocytes	NULL
,	NULL
but	NULL
a	NULL
number	NULL
of	NULL
B-cell	NULL
lines	NULL
can	NULL
be	NULL
triggered	NULL
into	NULL
the	NULL
lytic	NULL
cycle	NULL
by	NULL
treatment	NULL
with	NULL
inducing	NULL
agents	NULL
such	NULL
as	NULL
tetradecanoyl	NULL
phorbol	NULL
acetate	NULL
(	NULL
TPA	NULL
)	NULL
and	NULL
sodium	NULL
butyrate	NULL
(	NULL
33	NULL
,	NULL
51	NULL
)	NULL
.	NULL

These	NULL
agents	NULL
promote	NULL
expression	NULL
of	NULL
the	NULL
viral	NULL
BZLF1	NULL
gene	NULL
product	NULL
,	NULL
ZEBRA	NULL
.	NULL

Transfer	NULL
of	NULL
ZEBRA-expressing	NULL
plasmids	NULL
into	NULL
latently	NULL
infected	NULL
cell	NULL
lines	NULL
is	NULL
sufficient	NULL
to	NULL
disrupt	NULL
latency	NULL
as	NULL
measured	NULL
by	NULL
expression	NULL
of	NULL
lytic	NULL
cycle	NULL
genes	NULL
and	NULL
production	NULL
of	NULL
mature	NULL
virus	NULL
(	NULL
12	NULL
,	NULL
40	NULL
,	NULL
45	NULL
)	NULL
.	NULL

The	NULL
precise	NULL
mechanism	NULL
by	NULL
which	NULL
the	NULL
ZEBRA	NULL
protein	NULL
initiates	NULL
the	NULL
cascade	NULL
of	NULL
events	NULL
leading	NULL
to	NULL
virus	NULL
production	NULL
is	NULL
not	NULL
known	NULL
.	NULL

ZEBRA	NULL
is	NULL
a	NULL
transcriptional	NULL
activator	NULL
;	NULL
it	NULL
is	NULL
thought	NULL
to	NULL
disrupt	NULL
EBV	NULL
latency	NULL
by	NULL
activating	NULL
the	NULL
transcription	NULL
of	NULL
viral	NULL
lytic	NULL
cycle	NULL
promoters	NULL
(	NULL
8	NULL
,	NULL
22	NULL
,	NULL
27	NULL
,	NULL
41	NULL
)	NULL
.	NULL

The	NULL
ZEBRA	NULL
protein	NULL
is	NULL
a	NULL
member	NULL
of	NULL
the	NULL
bZIP	NULL
family	NULL
of	NULL
proteins	NULL
and	NULL
shares	NULL
extensive	NULL
homology	NULL
with	NULL
c-Fos	NULL
and	NULL
c-Jun	NULL
in	NULL
a	NULL
highly	NULL
basic	NULL
region	NULL
that	NULL
serves	NULL
as	NULL
the	NULL
DNA-binding	NULL
domain	NULL
for	NULL
this	NULL
class	NULL
of	NULL
proteins	NULL
(	NULL
20	NULL
)	NULL
.	NULL

Like	NULL
c-Fos	NULL
and	NULL
c-Jun	NULL
,	NULL
ZEBRA	NULL
binds	NULL
to	NULL
AP-1	NULL
heptamer	NULL
sites	NULL
as	NULL
a	NULL
dimer	NULL
;	NULL
however	NULL
,	NULL
ZEBRA	NULL
also	NULL
binds	NULL
specifically	NULL
to	NULL
several	NULL
other	NULL
sites	NULL
that	NULL
diverge	NULL
from	NULL
the	NULL
AP-1	NULL
consensus	NULL
sequence	NULL
(	NULL
6	NULL
,	NULL
22	NULL
,	NULL
31	NULL
,	NULL
37	NULL
,	NULL
46	NULL
)	NULL
.	NULL

These	NULL
sites	NULL
are	NULL
referred	NULL
to	NULL
as	NULL
ZEBRA	NULL
response	NULL
elements	NULL
(	NULL
ZREs	NULL
)	NULL
and	NULL
comprise	NULL
a	NULL
steadily	NULL
growing	NULL
list	NULL
of	NULL
different	NULL
sequences	NULL
with	NULL
a	NULL
consensus	NULL
of	NULL
T	NULL
(	NULL
G/T	NULL
)	NULL
(	NULL
T/A	NULL
)	NULL
G	NULL
(	NULL
T/C	NULL
)	NULL
(	NULL
C/A	NULL
)	NULL
A	NULL
(	NULL
4a	NULL
)	NULL
.	NULL

However	NULL
,	NULL
AP-1	NULL
activators	NULL
,	NULL
such	NULL
as	NULL
c-Fos	NULL
and	NULL
c-Jun	NULL
,	NULL
do	NULL
not	NULL
bind	NULL
to	NULL
ZREs	NULL
(	NULL
6	NULL
)	NULL
.	NULL

ZEBRA	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
activate	NULL
transcription	NULL
from	NULL
het-	NULL
*	NULL
Corresponding	NULL
author	NULL
.	NULL

Mailing	NULL
address	NULL
:	NULL
Department	NULL
of	NULL
Molecular	NULL
Biophysics	NULL
and	NULL
Biochemistry	NULL
,	NULL
Yale	NULL
University	NULL
,	NULL
333	NULL
Cedar	NULL
St.	NULL
,	NULL
New	NULL
Haven	NULL
,	NULL
CT	NULL
06510	NULL
.	NULL

Phone	NULL
:	NULL
(	NULL
203	NULL
)	NULL
785-4758	NULL
.	NULL

Fax	NULL
:	NULL
(	NULL
203	NULL
)	NULL
785-7194	NULL
.	NULL

E-mail	NULL
:	NULL
George_Miller	NULL
@	NULL
gm.yale.edu	NULL
.	NULL

3054	NULL
erologous	NULL
promoters	NULL
containing	NULL
oligomerized	NULL
AP-1	NULL
sites	NULL
or	NULL
ZREs	NULL
as	NULL
well	NULL
as	NULL
from	NULL
intact	NULL
promoter	NULL
sequences	NULL
from	NULL
EBV	NULL
early	NULL
lytic	NULL
cycle	NULL
genes	NULL
(	NULL
5	NULL
,	NULL
8	NULL
,	NULL
22	NULL
,	NULL
27	NULL
,	NULL
41	NULL
)	NULL
.	NULL

ZEBRA	NULL
's	NULL
transcriptional	NULL
activation	NULL
domain	NULL
resides	NULL
primarily	NULL
in	NULL
the	NULL
N-terminal	NULL
100	NULL
amino	NULL
acids	NULL
of	NULL
the	NULL
protein	NULL
and	NULL
can	NULL
function	NULL
in	NULL
a	NULL
wide	NULL
range	NULL
of	NULL
eukaryotic	NULL
cells	NULL
,	NULL
from	NULL
Saccharomyces	NULL
cerevisiae	NULL
to	NULL
human	NULL
B	NULL
lymphocytes	NULL
(	NULL
13	NULL
,	NULL
24	NULL
,	NULL
36	NULL
)	NULL
.	NULL

Additionally	NULL
,	NULL
ZEBRA	NULL
's	NULL
role	NULL
in	NULL
transcriptional	NULL
activation	NULL
has	NULL
been	NULL
studied	NULL
in	NULL
vitro	NULL
with	NULL
purified	NULL
basal	NULL
transcription	NULL
components	NULL
,	NULL
and	NULL
ZEBRA	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
stabilize	NULL
the	NULL
TFIIA-TFIID	NULL
complex	NULL
bound	NULL
to	NULL
promoter	NULL
DNA	NULL
(	NULL
9	NULL
,	NULL
10	NULL
,	NULL
28	NULL
,	NULL
32	NULL
)	NULL
.	NULL

A	NULL
chimeric	NULL
protein	NULL
in	NULL
which	NULL
the	NULL
basic	NULL
region	NULL
of	NULL
ZEBRA	NULL
was	NULL
replaced	NULL
with	NULL
that	NULL
of	NULL
c-Fos	NULL
did	NULL
not	NULL
retain	NULL
the	NULL
capacity	NULL
to	NULL
disrupt	NULL
latency	NULL
(	NULL
30	NULL
)	NULL
.	NULL

This	NULL
result	NULL
suggested	NULL
that	NULL
transcriptional	NULL
activation	NULL
through	NULL
ZREs	NULL
that	NULL
are	NULL
uniquely	NULL
recognized	NULL
by	NULL
ZEBRA	NULL
and	NULL
not	NULL
by	NULL
ZEBRA/Fos	NULL
chimeras	NULL
are	NULL
important	NULL
for	NULL
entry	NULL
into	NULL
the	NULL
lytic	NULL
cycle	NULL
.	NULL

The	NULL
X-ray	NULL
crystal	NULL
structure	NULL
of	NULL
Fos-Jun	NULL
bound	NULL
to	NULL
an	NULL
AP-1	NULL
site	NULL
provided	NULL
a	NULL
starting	NULL
point	NULL
in	NULL
identifying	NULL
the	NULL
amino	NULL
acids	NULL
in	NULL
the	NULL
basic	NULL
region	NULL
of	NULL
ZEBRA	NULL
that	NULL
might	NULL
contribute	NULL
to	NULL
its	NULL
capacity	NULL
to	NULL
recognize	NULL
ZREs	NULL
specifically	NULL
(	NULL
25	NULL
)	NULL
.	NULL

Five	NULL
amino	NULL
acids	NULL
in	NULL
the	NULL
basic	NULL
domain	NULL
of	NULL
each	NULL
partner	NULL
in	NULL
the	NULL
Fos-Jun	NULL
heterodimer	NULL
made	NULL
specific	NULL
contacts	NULL
with	NULL
bases	NULL
in	NULL
the	NULL
AP-1	NULL
DNA	NULL
element	NULL
.	NULL

ZEBRA	NULL
shares	NULL
identity	NULL
in	NULL
four	NULL
of	NULL
these	NULL
contacting	NULL
amino	NULL
acids	NULL
at	NULL
the	NULL
level	NULL
of	NULL
primary	NULL
structure	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
.	NULL

Whereas	NULL
both	NULL
c-Fos	NULL
and	NULL
c-Jun	NULL
have	NULL
highly	NULL
conserved	NULL
ala-nines	NULL
that	NULL
contact	NULL
a	NULL
thymine	NULL
at	NULL
position	NULL
+1	NULL
from	NULL
the	NULL
center	NULL
of	NULL
the	NULL
DNA	NULL
recognition	NULL
element	NULL
,	NULL
tgAcTca	NULL
(	NULL
contacting	NULL
bases	NULL
are	NULL
in	NULL
uppercase	NULL
letters	NULL
)	NULL
,	NULL
ZEBRA	NULL
has	NULL
a	NULL
serine	NULL
at	NULL
the	NULL
equivalent	NULL
position	NULL
,	NULL
amino	NULL
acid	NULL
186	NULL
.	NULL

This	NULL
difference	NULL
in	NULL
a	NULL
crucial	NULL
amino	NULL
acid	NULL
in	NULL
the	NULL
DNA	NULL
recognition	NULL
domain	NULL
of	NULL
the	NULL
protein	NULL
may	NULL
account	NULL
for	NULL
ZEBRA	NULL
's	NULL
diversity	NULL
of	NULL
binding	NULL
compared	NULL
with	NULL
other	NULL
AP-1	NULL
factors	NULL
.	NULL

Thus	NULL
,	NULL
it	NULL
was	NULL
hypothesized	NULL
that	NULL
a	NULL
substitution	NULL
of	NULL
alanine	NULL
for	NULL
the	NULL
serine	NULL
at	NULL
position	NULL
186	NULL
(	NULL
S186AÂ¥	NULL
)	NULL
would	NULL
convert	NULL
the	NULL
DNA-binding	NULL
specificity	NULL
of	NULL
ZEBRA	NULL
to	NULL
that	NULL
of	NULL
c-Jun	NULL
and	NULL
Vor	NULL
.	NULL

71	NULL
,	NULL
1997	NULL
Â»	NULL
t	NULL
p	NULL
A	NULL
D	NULL
aa	NULL
.	NULL

139	NULL
K	NULL
ROR	NULL
I	NULL
R	NULL
R	NULL
E	NULL
RINK	NULL
M|AjlA	NULL
263	NULL
K	NULL
A	NULL
E	NULL
R	NULL
KOR	NULL
M	NULL
R	NULL
R	NULL
I1	NULL
[	NULL
AJA	NULL
227	NULL
P	NULL
A	NULL
A	NULL
L	NULL
KOR	NULL
A	NULL
RIN|T	NULL
E	NULL
|Ajla	NULL
174	NULL
E	NULL
L	NULL
OED	NULL
KOR	NULL
Y	NULL
K	NULL
R	NULL
V	NULL
|A|Â®	NULL
174	NULL
E	NULL
L	NULL
EOI	NULL
KOR	NULL
Y	NULL
V	NULL
|a	NULL
[	NULL
A	NULL
186	NULL
Z	NULL
(	NULL
S1B6A	NULL
)	NULL
FAILS	NULL
TO	NULL
DISRUPT	NULL
LATENCY	NULL
_	NULL
3055	NULL
K	NULL
[	NULL
C|R|N	NULL
R	NULL
R	NULL
R	NULL
E	NULL
L	NULL
T	NULL
D	NULL
Fos	NULL
K	NULL
[	NULL
CIR	NULL
|K	NULL
R	NULL
K	NULL
L	NULL
E	NULL
R	NULL
1	NULL
A	NULL
-	NULL
Jun	NULL
R	NULL
[	NULL
S	NULL
JJR	NULL
|A	NULL
R	NULL
K	NULL
L	NULL
Q	NULL
R	NULL
M	NULL
K__	NULL
GCN4	NULL
K	NULL
F	NULL
K	NULL
Q	NULL
L	NULL
L	NULL
Q	NULL
_	NULL
ZEBRA	NULL
KICJ|R	NULL
|A	NULL
K	NULL
F	NULL
K	NULL
Q	NULL
L	NULL
L	NULL
Q	NULL
Z	NULL
(	NULL
S1864	NULL
)	NULL
FIG	NULL
.	NULL

1	NULL
.	NULL

Comparison	NULL
of	NULL
the	NULL
amino	NULL
acid	NULL
sequences	NULL
of	NULL
the	NULL
basic	NULL
DNA-binding	NULL
regions	NULL
of	NULL
members	NULL
of	NULL
the	NULL
bZIP	NULL
family	NULL
of	NULL
proteins	NULL
.	NULL

Amino	NULL
acids	NULL
in	NULL
the	NULL
GCN4	NULL
homodimer	NULL
and	NULL
the	NULL
Fos-Jun	NULL
heterodimer	NULL
that	NULL
were	NULL
shown	NULL
to	NULL
contact	NULL
DNA	NULL
bases	NULL
in	NULL
crystal	NULL
structures	NULL
are	NULL
boxed	NULL
(	NULL
19	NULL
,	NULL
25	NULL
)	NULL
.	NULL

The	NULL
serine	NULL
at	NULL
amino	NULL
acid	NULL
position	NULL
186	NULL
in	NULL
the	NULL
ZEBRA	NULL
protein	NULL
that	NULL
differs	NULL
from	NULL
the	NULL
highly	NULL
conserved	NULL
alanine	NULL
found	NULL
at	NULL
the	NULL
equivalent	NULL
position	NULL
in	NULL
the	NULL
majority	NULL
of	NULL
bZIP	NULL
proteins	NULL
is	NULL
circled	NULL
.	NULL

Z	NULL
(	NULL
S186A	NULL
)	NULL
is	NULL
a	NULL
PCR-generated	NULL
point	NULL
mutant	NULL
[	NULL
Ser	NULL
(	NULL
TCC	NULL
)	NULL
-	NULL
>	NULL
Ala	NULL
(	NULL
GCC	NULL
)	NULL
]	NULL
of	NULL
the	NULL
ZEBRA	NULL
protein	NULL
that	NULL
restores	NULL
the	NULL
conserved	NULL
alanine	NULL
at	NULL
position	NULL
186.	NULL
c-Fos	NULL
.	NULL

Since	NULL
the	NULL
DNA-binding	NULL
specificity	NULL
of	NULL
ZEBRA	NULL
would	NULL
be	NULL
expected	NULL
to	NULL
affect	NULL
its	NULL
function	NULL
in	NULL
vivo	NULL
,	NULL
we	NULL
assessed	NULL
the	NULL
phenotype	NULL
of	NULL
such	NULL
a	NULL
mutant	NULL
,	NULL
Z	NULL
(	NULL
S186A	NULL
)	NULL
,	NULL
with	NULL
respect	NULL
to	NULL
DNA	NULL
binding	NULL
in	NULL
vitro	NULL
,	NULL
transcriptional	NULL
activation	NULL
,	NULL
and	NULL
the	NULL
ability	NULL
to	NULL
disrupt	NULL
EBV	NULL
latency	NULL
in	NULL
B	NULL
cells	NULL
.	NULL

Interestingly	NULL
,	NULL
the	NULL
mutation	NULL
of	NULL
amino	NULL
acid	NULL
186	NULL
of	NULL
ZEBRA	NULL
to	NULL
alanine	NULL
did	NULL
not	NULL
dramatically	NULL
change	NULL
the	NULL
DNA-binding	NULL
specificity	NULL
or	NULL
transcriptional	NULL
activation	NULL
properties	NULL
of	NULL
the	NULL
protein	NULL
;	NULL
however	NULL
,	NULL
unexpectedly	NULL
,	NULL
this	NULL
mutation	NULL
abolished	NULL
the	NULL
protein	NULL
's	NULL
ability	NULL
to	NULL
promote	NULL
entry	NULL
of	NULL
EBV	NULL
into	NULL
its	NULL
lytic	NULL
cycle	NULL
.	NULL

Thus	NULL
,	NULL
alteration	NULL
of	NULL
a	NULL
single	NULL
amino	NULL
acid	NULL
in	NULL
the	NULL
basic	NULL
domain	NULL
of	NULL
ZEBRA	NULL
can	NULL
separate	NULL
its	NULL
transcriptional	NULL
activation	NULL
and	NULL
disruption	NULL
of	NULL
latency	NULL
functions	NULL
.	NULL

This	NULL
suggests	NULL
that	NULL
a	NULL
property	NULL
in	NULL
addition	NULL
to	NULL
transcriptional	NULL
activation	NULL
is	NULL
required	NULL
for	NULL
initiation	NULL
of	NULL
the	NULL
lytic	NULL
cascade	NULL
by	NULL
ZEBRA	NULL
.	NULL

MATERIALS	NULL
AND	NULL
METHODS	NULL
Constructs	NULL
for	NULL
overexpression	NULL
of	NULL
ZEBRA	NULL
and	NULL
its	NULL
mutants	NULL
in	NULL
bacteria	NULL
.	NULL

Bacterial	NULL
expression	NULL
constructs	NULL
of	NULL
ZEBRA	NULL
,	NULL
Z	NULL
(	NULL
S186A	NULL
)	NULL
,	NULL
ZA131	NULL
,	NULL
and	NULL
ZFZ	NULL
[	NULL
Z	NULL
(	NULL
1-171	NULL
)	NULL
/	NULL
Fos	NULL
(	NULL
137-162	NULL
)	NULL
/Z	NULL
(	NULL
198-245	NULL
)	NULL
]	NULL
were	NULL
cloned	NULL
into	NULL
the	NULL
Nco	NULL
!	NULL

and	NULL
BamHI	NULL
sites	NULL
of	NULL
pET-11d	NULL
,	NULL
allowing	NULL
for	NULL
expression	NULL
from	NULL
T7	NULL
promoter	NULL
sequences	NULL
(	NULL
9	NULL
)	NULL
.	NULL

Inserts	NULL
were	NULL
generated	NULL
by	NULL
PCR	NULL
with	NULL
the	NULL
BZLF1	NULL
cDNA	NULL
in	NULL
pSP64	NULL
or	NULL
ZFZ	NULL
in	NULL
pHD1013	NULL
as	NULL
a	NULL
template	NULL
(	NULL
30	NULL
,	NULL
41	NULL
)	NULL
.	NULL

All	NULL
PCR	NULL
reactions	NULL
were	NULL
carried	NULL
out	NULL
with	NULL
Taq	NULL
DNA	NULL
polymerase	NULL
(	NULL
Boehringer	NULL
Mannheim	NULL
)	NULL
for	NULL
30	NULL
cycles	NULL
with	NULL
an	NULL
annealing	NULL
temperature	NULL
of	NULL
50Â°C	NULL
.	NULL

The	NULL
$	NULL
186A	NULL
mutation	NULL
was	NULL
introduced	NULL
by	NULL
a	NULL
primary	NULL
PCR	NULL
step	NULL
in	NULL
which	NULL
two	NULL
separate	NULL
PCR	NULL
reactions	NULL
were	NULL
carried	NULL
out	NULL
with	NULL
the	NULL
BZLF1	NULL
cDNA	NULL
as	NULL
a	NULL
template	NULL
.	NULL

A	NULL
568-bp	NULL
fragment	NULL
from	NULL
the	NULL
5Â°	NULL
end	NULL
of	NULL
the	NULL
BZLF1	NULL
cDNA	NULL
was	NULL
generated	NULL
with	NULL
a	NULL
primer	NULL
complementary	NULL
to	NULL
the	NULL
5	NULL
'	NULL
end	NULL
of	NULL
the	NULL
BZLF1	NULL
cDNA	NULL
that	NULL
introduced	NULL
an	NULL
Neo	NULL
!	NULL

site	NULL
and	NULL
a	NULL
mutagenic	NULL
primer	NULL
of	NULL
the	NULL
sequence	NULL
5'TITTTCTGGCAGCCACC	NULL
CGATTCTT3	NULL
'	NULL
which	NULL
was	NULL
complementary	NULL
to	NULL
the	NULL
DNA-binding	NULL
region	NULL
of	NULL
the	NULL
BZLF1	NULL
gene	NULL
between	NULL
codons	NULL
for	NULL
amino	NULL
acids	NULL
181	NULL
to	NULL
188	NULL
of	NULL
the	NULL
ZEBRA	NULL
protein	NULL
.	NULL

The	NULL
C	NULL
in	NULL
boldface	NULL
type	NULL
represents	NULL
a	NULL
mismatch	NULL
to	NULL
the	NULL
template	NULL
at	NULL
the	NULL
first	NULL
nucleotide	NULL
of	NULL
codon	NULL
186	NULL
which	NULL
introduced	NULL
a	NULL
change	NULL
from	NULL
TCC	NULL
(	NULL
serine	NULL
)	NULL
to	NULL
GCC	NULL
(	NULL
alanine	NULL
)	NULL
.	NULL

A	NULL
201-bp	NULL
fragment	NULL
of	NULL
the	NULL
3	NULL
'	NULL
end	NULL
of	NULL
the	NULL
BZLF1	NULL
cDNA	NULL
was	NULL
generated	NULL
with	NULL
a	NULL
primer	NULL
complementary	NULL
to	NULL
the	NULL
3	NULL
'	NULL
end	NULL
of	NULL
the	NULL
BZLF1	NULL
cDNA	NULL
that	NULL
introduced	NULL
a	NULL
BamHI	NULL
site	NULL
and	NULL
a	NULL
mutagenic	NULL
primer	NULL
of	NULL
the	NULL
sequence	NULL
5'GTGGCTGCCAGAA	NULL
AATGCCGG3	NULL
'	NULL
which	NULL
was	NULL
complementary	NULL
to	NULL
codons	NULL
for	NULL
amino	NULL
acids	NULL
184	NULL
to	NULL
190	NULL
of	NULL
the	NULL
ZEBRA	NULL
protein	NULL
with	NULL
a	NULL
mismatch	NULL
at	NULL
the	NULL
G	NULL
in	NULL
boldface	NULL
to	NULL
introduce	NULL
the	NULL
TCC	NULL
(	NULL
serine	NULL
)	NULL
-to-GCC	NULL
(	NULL
alanine	NULL
)	NULL
mutation	NULL
in	NULL
this	NULL
fragment	NULL
.	NULL

After	NULL
agarose	NULL
gel	NULL
electrophoresis	NULL
and	NULL
purification	NULL
of	NULL
5	NULL
'	NULL
and	NULL
3	NULL
'	NULL
PCR	NULL
fragments	NULL
on	NULL
glass	NULL
beads	NULL
,	NULL
a	NULL
secondary	NULL
PCR	NULL
step	NULL
was	NULL
performed	NULL
.	NULL

The	NULL
purified	NULL
5	NULL
'	NULL
and	NULL
3	NULL
'	NULL
fragments	NULL
of	NULL
the	NULL
BZLF1	NULL
cDNA	NULL
were	NULL
denatured	NULL
and	NULL
annealed	NULL
by	NULL
virtue	NULL
of	NULL
their	NULL
15-bp	NULL
overlap	NULL
(	NULL
codons	NULL
184	NULL
to	NULL
188	NULL
)	NULL
and	NULL
extended	NULL
by	NULL
Taq	NULL
DNA	NULL
polymerase	NULL
to	NULL
generate	NULL
a	NULL
755-bp	NULL
product	NULL
[	NULL
Z	NULL
(	NULL
S186A	NULL
)	NULL
]	NULL
that	NULL
represented	NULL
the	NULL
full-length	NULL
BZLF1	NULL
cDNA	NULL
with	NULL
a	NULL
TCC-GCC	NULL
change	NULL
at	NULL
codon	NULL
186	NULL
and	NULL
a	NULL
5'-end	NULL
Neo	NULL
site	NULL
and	NULL
3'-end	NULL
BamHI	NULL
site	NULL
.	NULL

This	NULL
product	NULL
served	NULL
as	NULL
the	NULL
template	NULL
for	NULL
PCR	NULL
amplification	NULL
with	NULL
the	NULL
5'-end	NULL
Neo	NULL
!	NULL

and	NULL
3'-end	NULL
BamHI	NULL
primers	NULL
and	NULL
was	NULL
cloned	NULL
into	NULL
pET-11d	NULL
to	NULL
generate	NULL
Z	NULL
(	NULL
S186A	NULL
)	NULL
.	NULL

The	NULL
Z	NULL
(	NULL
S186A	NULL
)	NULL
coding	NULL
sequence	NULL
that	NULL
was	NULL
cloned	NULL
into	NULL
pET-11d	NULL
was	NULL
sequenced	NULL
in	NULL
its	NULL
entirety	NULL
and	NULL
found	NULL
to	NULL
be	NULL
identical	NULL
to	NULL
the	NULL
wild-type	NULL
BZLF1	NULL
cDNA	NULL
except	NULL
at	NULL
codon	NULL
186	NULL
(	NULL
where	NULL
there	NULL
was	NULL
a	NULL
T-to-G	NULL
change	NULL
at	NULL
the	NULL
first	NULL
position	NULL
)	NULL
.	NULL

Eukaryotic	NULL
expression	NULL
constructs	NULL
.	NULL

The	NULL
EBV	NULL
genomic	NULL
BZLF1	NULL
sequence	NULL
contained	NULL
on	NULL
the	NULL
fragment	NULL
(	NULL
EBV	NULL
102115	NULL
to	NULL
103181	NULL
)	NULL
of	NULL
EBV	NULL
BamHI	NULL
Z	NULL
(	NULL
B95-8	NULL
)	NULL
was	NULL
cloned	NULL
into	NULL
pHD1013	NULL
,	NULL
which	NULL
utilizes	NULL
the	NULL
cytomegalovirus	NULL
(	NULL
CMV	NULL
)	NULL
immediate-carly	NULL
gene	NULL
promoter-enhancer	NULL
for	NULL
constitutive	NULL
expression	NULL
of	NULL
gene	NULL
products	NULL
in	NULL
mammalian	NULL
cells	NULL
(	NULL
1a	NULL
,	NULL
16	NULL
)	NULL
.	NULL

Genomic	NULL
ZVP	NULL
expressed	NULL
a	NULL
fusion	NULL
between	NULL
amino	NULL
acids	NULL
1	NULL
to	NULL
227	NULL
of	NULL
the	NULL
ZEBRA	NULL
protein	NULL
(	NULL
encoded	NULL
by	NULL
EBV	NULL
genomic	NULL
sequence	NULL
102266	NULL
to	NULL
103181	NULL
)	NULL
and	NULL
the	NULL
C-terminal	NULL
80	NULL
amino	NULL
acids	NULL
of	NULL
the	NULL
herpes	NULL
simplex	NULL
virus	NULL
type	NULL
1	NULL
activator	NULL
VP16	NULL
.	NULL

Genomic	NULL
clones	NULL
of	NULL
Z	NULL
(	NULL
S186A	NULL
)	NULL
and	NULL
Z	NULL
(	NULL
S186T	NULL
)	NULL
were	NULL
generated	NULL
by	NULL
a	NULL
two-step	NULL
PCR	NULL
process	NULL
with	NULL
genomic	NULL
BZLF1	NULL
in	NULL
BXG1	NULL
as	NULL
a	NULL
template	NULL
(	NULL
5	NULL
)	NULL
.	NULL

Genomic	NULL
Z	NULL
(	NULL
S186A	NULL
)	NULL
was	NULL
constructed	NULL
with	NULL
the	NULL
same	NULL
mutagenic	NULL
primers	NULL
described	NULL
above	NULL
and	NULL
nonmutagenic	NULL
primers	NULL
that	NULL
introduced	NULL
a	NULL
5'-end	NULL
Xbel	NULL
site	NULL
at	NULL
the	NULL
Nee	NULL
!	NULL

site	NULL
of	NULL
Bam	NULL
Z	NULL
and	NULL
a	NULL
3'-end	NULL
BamHI	NULL
site	NULL
at	NULL
the	NULL
Neo	NULL
!	NULL

site	NULL
of	NULL
Bam	NULL
Z.	NULL
Genomic	NULL
Z	NULL
(	NULL
S186T	NULL
)	NULL
was	NULL
constructed	NULL
with	NULL
the	NULL
same	NULL
nonmutagenic	NULL
5'-end	NULL
Xbel	NULL
and	NULL
3'-end	NULL
BamHI	NULL
primers	NULL
and	NULL
mutagenic	NULL
primers	NULL
that	NULL
introduced	NULL
a	NULL
TCC	NULL
(	NULL
serine	NULL
)	NULL
-to-ACC	NULL
(	NULL
threonine	NULL
)	NULL
change	NULL
at	NULL
codon	NULL
186	NULL
of	NULL
BZLF1	NULL
by	NULL
the	NULL
same	NULL
strategy	NULL
as	NULL
described	NULL
for	NULL
Z	NULL
(	NULL
S186A	NULL
)	NULL
.	NULL

Genomic	NULL
inserts	NULL
bearing	NULL
mutations	NULL
at	NULL
codon	NULL
186	NULL
were	NULL
cloned	NULL
into	NULL
the	NULL
Xbal	NULL
and	NULL
BamHI	NULL
sites	NULL
in	NULL
the	NULL
polylinker	NULL
of	NULL
pHD1013	NULL
.	NULL

The	NULL
genomic	NULL
Z	NULL
(	NULL
$	NULL
186A	NULL
)	NULL
insert	NULL
was	NULL
sequenced	NULL
in	NULL
its	NULL
entirety	NULL
and	NULL
found	NULL
to	NULL
be	NULL
identical	NULL
to	NULL
wild-type	NULL
genomic	NULL
BZLF1	NULL
except	NULL
at	NULL
codon	NULL
186	NULL
(	NULL
where	NULL
there	NULL
was	NULL
a	NULL
T-to-G	NULL
change	NULL
at	NULL
the	NULL
first	NULL
position	NULL
)	NULL
.	NULL

Preparation	NULL
of	NULL
protein	NULL
extracts	NULL
.	NULL

Escherichia	NULL
coli	NULL
BL21	NULL
(	NULL
DE3	NULL
)	NULL
,	NULL
featuring	NULL
induc-ible	NULL
T7	NULL
RNA	NULL
polymerase	NULL
expression	NULL
,	NULL
was	NULL
transformed	NULL
with	NULL
constructs	NULL
expressing	NULL
ZEBRA	NULL
,	NULL
Z	NULL
(	NULL
S186A	NULL
)	NULL
,	NULL
or	NULL
ZFZ	NULL
from	NULL
pET-11d	NULL
or	NULL
with	NULL
pET-11d	NULL
alone	NULL
.	NULL

BL21	NULL
(	NULL
DE3	NULL
)	NULL
pLysS	NULL
was	NULL
used	NULL
to	NULL
overexpress	NULL
ZA131	NULL
.	NULL

Ampicillin-resistant	NULL
cultures	NULL
were	NULL
grown	NULL
to	NULL
an	NULL
optical	NULL
density	NULL
at	NULL
600	NULL
nm	NULL
of	NULL
0.6	NULL
to	NULL
0.7	NULL
and	NULL
induced	NULL
with	NULL
isopropyl-B-p-thiogalactopyranoside	NULL
(	NULL
IPTG	NULL
)	NULL
at	NULL
1	NULL
mM	NULL
for	NULL
4	NULL
h.	NULL
Induced	NULL
cultures	NULL
were	NULL
harvested	NULL
at	NULL
4Â°C	NULL
,	NULL
and	NULL
pellets	NULL
were	NULL
resuspended	NULL
in	NULL
1/5	NULL
volume	NULL
of	NULL
6	NULL
M	NULL
urea	NULL
and	NULL
sonicated	NULL
on	NULL
ice	NULL
for	NULL
eight	NULL
rounds	NULL
of	NULL
15	NULL
s	NULL
each	NULL
.	NULL

Extracts	NULL
were	NULL
then	NULL
dialyzed	NULL
three	NULL
times	NULL
(	NULL
45	NULL
min	NULL
each	NULL
)	NULL
against	NULL
DNA-binding	NULL
buffer	NULL
,	NULL
containing	NULL
75	NULL
mM	NULL
KCI	NULL
5	NULL
mM	NULL
MgCl	NULL
,	NULL
,	NULL
10	NULL
mM	NULL
HEPES	NULL
(	NULL
pH	NULL
7.5	NULL
)	NULL
,	NULL
0.5	NULL
mM	NULL
EGTA	NULL
,	NULL
0.5	NULL
mM	NULL
dithiothreitol	NULL
,	NULL
and	NULL
15	NULL
%	NULL
glycerol	NULL
.	NULL

Aliquots	NULL
of	NULL
protein	NULL
extracts	NULL
were	NULL
stored	NULL
at	NULL
-70Â°C	NULL
until	NULL
use	NULL
in	NULL
binding	NULL
reactions	NULL
.	NULL

The	NULL
relative	NULL
amounts	NULL
of	NULL
ZEBRA	NULL
,	NULL
Z	NULL
(	NULL
S186A	NULL
)	NULL
,	NULL
and	NULL
ZFZ	NULL
present	NULL
in	NULL
equivalent	NULL
volumes	NULL
of	NULL
extract	NULL
were	NULL
determined	NULL
by	NULL
sodium	NULL
dodecyl	NULL
sulfate-poly-acrylamide	NULL
gel	NULL
electrophoresis	NULL
(	NULL
SDS-PAGE	NULL
)	NULL
and	NULL
immunoblotting	NULL
with	NULL
rabbit	NULL
antiserum	NULL
to	NULL
ZEBRA	NULL
and	NULL
***I-protein	NULL
A.	NULL
Quantitation	NULL
of	NULL
immunoreactive	NULL
bands	NULL
on	NULL
the	NULL
Western	NULL
blot	NULL
was	NULL
accomplished	NULL
by	NULL
phosphorimaging	NULL
.	NULL

Induced	NULL
extracts	NULL
contained	NULL
roughly	NULL
equivalent	NULL
amounts	NULL
of	NULL
ZEBRA	NULL
and	NULL
Z	NULL
(	NULL
S186A	NULL
)	NULL
;	NULL
ZFZ	NULL
extracts	NULL
were	NULL
roughly	NULL
half	NULL
as	NULL
concentrated	NULL
.	NULL

DNA-binding	NULL
assays	NULL
.	NULL

Binding	NULL
reaction	NULL
mixtures	NULL
contained	NULL
1	NULL
pl	NULL
of	NULL
each	NULL
protein	NULL
extract	NULL
(	NULL
except	NULL
where	NULL
indicated	NULL
)	NULL
and	NULL
5	NULL
%	NULL
10Â°	NULL
cpm	NULL
of	NULL
duplex	NULL
oligonucleotide	NULL
that	NULL
had	NULL
been	NULL
labelled	NULL
with	NULL
[	NULL
y-*	NULL
``	NULL
P	NULL
]	NULL
dATP	NULL
by	NULL
T4	NULL
polynucleotide	NULL
kinase	NULL
(	NULL
New	NULL
England	NULL
Biolabs	NULL
)	NULL
.	NULL

The	NULL
binding	NULL
reactions	NULL
were	NULL
carried	NULL
out	NULL
in	NULL
DNA-binding	NULL
buffer	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
1	NULL
pg	NULL
of	NULL
poly	NULL
(	NULL
dI-dC	NULL
)	NULL
for	NULL
10	NULL
min	NULL
at	NULL
room	NULL
temperature	NULL
with	NULL
the	NULL
exception	NULL
of	NULL
the	NULL
ZA131	NULL
competition	NULL
reactions	NULL
,	NULL
which	NULL
involved	NULL
incubation	NULL
for	NULL
30	NULL
min	NULL
at	NULL
room	NULL
temperature	NULL
.	NULL

Reaction	NULL
mixtures	NULL
were	NULL
subjected	NULL
to	NULL
electrophoresis	NULL
on	NULL
a	NULL
4	NULL
%	NULL
polyacrylamide	NULL
gel	NULL
in	NULL
0.5	NULL
%	NULL
Tris-borate-EDTA	NULL
buffer	NULL
at	NULL
200	NULL
V.	NULL
The	NULL
gels	NULL
were	NULL
dried	NULL
,	NULL
exposed	NULL
to	NULL
film	NULL
overnight	NULL
,	NULL
and	NULL
then	NULL
subjected	NULL
to	NULL
phosphorimage	NULL
analysis	NULL
(	NULL
Molecular	NULL
Dynamics	NULL
)	NULL
.	NULL

Quantitated	NULL
bands	NULL
representing	NULL
free	NULL
and	NULL
bound	NULL
probe	NULL
were	NULL
corrected	NULL
for	NULL
background	NULL
and	NULL
used	NULL
to	NULL
calculate	NULL
the	NULL
percentage	NULL
of	NULL
probe	NULL
shifted	NULL
by	NULL
binding	NULL
to	NULL
protein	NULL
.	NULL

Probes	NULL
containing	NULL
the	NULL
heptamer	NULL
ZEBRA	NULL
recognition	NULL
elements	NULL
ZRE-R	NULL
(	NULL
TGAGCGA	NULL
)	NULL
,	NULL
ZMA	NULL
(	NULL
TGAGCCA	NULL
)	NULL
,	NULL
and	NULL
ZIIIB	NULL
(	NULL
TTAGCAA	NULL
)	NULL
and	NULL
the	NULL
AP-1	NULL
octamer	NULL
(	NULL
TGACATCA	NULL
)	NULL
were	NULL
synthesized	NULL
to	NULL
contain	NULL
identical	NULL
top-strand	NULL
and	NULL
bottom-strand	NULL
flanking	NULL
sequences	NULL
(	NULL
22	NULL
,	NULL
37	NULL
)	NULL
(	NULL
where	NULL
each	NULL
X	NULL
represents	NULL
a	NULL
nucleotide	NULL
of	NULL
an	NULL
inserted	NULL
heptamer	NULL
or	NULL
octamer	NULL
)	NULL
.	NULL

Cell	NULL
culture	NULL
and	NULL
transfections	NULL
.	NULL

The	NULL
EBV-positive	NULL
human	NULL
Burkitt	NULL
's	NULL
lymphoma	NULL
line	NULL
Raji	NULL
,	NULL
which	NULL
is	NULL
limited	NULL
to	NULL
expression	NULL
of	NULL
early	NULL
viral	NULL
genes	NULL
,	NULL
was	NULL
grown	NULL
in	NULL
RPMI	NULL
1640	NULL
medium	NULL
containing	NULL
8	NULL
%	NULL
fetal	NULL
bovine	NULL
serum	NULL
.	NULL

A	NULL
total	NULL
of	NULL
1.5	NULL
x	NULL
10	NULL
``	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
CsCl-purified	NULL
DNA	NULL
by	NULL
electroporation	NULL
according	NULL
to	NULL
published	NULL
methods	NULL
(	NULL
30	NULL
)	NULL
.	NULL

SDS-PAGE	NULL
and	NULL
immunoblotting	NULL
.	NULL

Protein	NULL
extracts	NULL
were	NULL
prepared	NULL
from	NULL
transfected	NULL
cells	NULL
that	NULL
had	NULL
grown	NULL
in	NULL
culture	NULL
for	NULL
3	NULL
days	NULL
.	NULL

Cells	NULL
were	NULL
harvested	NULL
by	NULL
centrifugation	NULL
,	NULL
resuspended	NULL
in	NULL
SDS	NULL
sample	NULL
buffer	NULL
,	NULL
and	NULL
sonicated	NULL
for	NULL
15	NULL
s.	NULL
Samples	NULL
containing	NULL
3	NULL
X	NULL
10Â°	NULL
cells	NULL
were	NULL
boiled	NULL
and	NULL
electrophoresed	NULL
through	NULL
a	NULL
10	NULL
%	NULL
polyacrylamide-SDS	NULL
gel	NULL
before	NULL
the	NULL
proteins	NULL
were	NULL
transferred	NULL
to	NULL
nitrocellulose	NULL
.	NULL

The	NULL
Western	NULL
blot	NULL
was	NULL
reacted	NULL
with	NULL
a	NULL
1:200	NULL
dilution	NULL
of	NULL
a	NULL
monospecific	NULL
polyclonal	NULL
antiserum	NULL
raised	NULL
against	NULL
ZEBRA	NULL
,	NULL
and	NULL
this	NULL
was	NULL
followed	NULL
by	NULL
incubation	NULL
with	NULL
a	NULL
1:100	NULL
dilution	NULL
of	NULL
the	NULL
R3.1	NULL
mouse	NULL
monoclonal	NULL
antibody	NULL
directed	NULL
against	NULL
the	NULL
EA	NULL
proteins	NULL
and	NULL
a	NULL
rabbit-antimouse	NULL
bridge	NULL
(	NULL
11	NULL
,	NULL
45	NULL
)	NULL
.	NULL

Immunoreactive	NULL
bands	NULL
were	NULL
detected	NULL
with	NULL
***I-protein	NULL
A	NULL
and	NULL
autoradiographed	NULL
.	NULL

CAT	NULL
assays	NULL
.	NULL

Cells	NULL
transfected	NULL
with	NULL
reporter	NULL
and	NULL
activator	NULL
DNAs	NULL
were	NULL
grown	NULL
in	NULL
suspension	NULL
for	NULL
3	NULL
days	NULL
prior	NULL
to	NULL
assaying	NULL
for	NULL
chloramphenicol	NULL
acetyltransferase	NULL
(	NULL
CAT	NULL
)	NULL
activity	NULL
.	NULL

Cells	NULL
were	NULL
lysed	NULL
with	NULL
reporter	NULL
lysis	NULL
buffer	NULL
,	NULL
and	NULL
extracts	NULL
were	NULL
prepared	NULL
via	NULL
the	NULL
Luciferase	NULL
Assay	NULL
System	NULL
(	NULL
Promega	NULL
)	NULL
.	NULL

A	NULL
5-ul	NULL
aliquot	NULL
of	NULL
lysed-cell	NULL
supernatant	NULL
was	NULL
assayed	NULL
for	NULL
CAT	NULL
activity	NULL
for	NULL
1	NULL
h	NULL
at	NULL
37Â°C	NULL
.	NULL

Stimulation	NULL
was	NULL
calculated	NULL
by	NULL
dividing	NULL
the	NULL
percent	NULL
acetylation	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
each	NULL
activator	NULL
by	NULL
3056	NULL
FRANCIS	NULL
ET	NULL
AL	NULL
.	NULL

PROTEIN	NULL
<	NULL
so	NULL
h	NULL
A	NULL
2	NULL
E	NULL
a.	NULL
N	NULL
N	NULL
N	NULL
PROBE	NULL
1	NULL
.	NULL

2	NULL
8	NULL
4	NULL
TTAGCAA	NULL
(	NULL
Zil18	NULL
)	NULL
h-TGAGCGA	NULL
(	NULL
ZRE-R	NULL
)	NULL
wy	NULL
Â«	NULL
==	NULL
TGAGCCA	NULL
(	NULL
ZilIA	NULL
)	NULL
..-TGACATCA	NULL
(	NULL
AP-1	NULL
OCT	NULL
)	NULL
rag	NULL
tres	NULL
FIG	NULL
.	NULL

2	NULL
.	NULL

Comparison	NULL
of	NULL
the	NULL
DNA-binding	NULL
activities	NULL
of	NULL
ZEBRA	NULL
and	NULL
the	NULL
Z	NULL
(	NULL
S186A	NULL
)	NULL
mutant	NULL
protein	NULL
.	NULL

Shown	NULL
are	NULL
the	NULL
results	NULL
of	NULL
an	NULL
EMSA	NULL
of	NULL
lysates	NULL
containing	NULL
bacterially	NULL
expressed	NULL
ZEBRA	NULL
,	NULL
Z	NULL
(	NULL
S186A	NULL
)	NULL
,	NULL
or	NULL
ZFZ	NULL
protein	NULL
with	NULL
duplex	NULL
oligonucleotide	NULL
probes	NULL
harboring	NULL
one	NULL
of	NULL
the	NULL
known	NULL
ZEBRA	NULL
binding	NULL
sites	NULL
,	NULL
ZRE-R	NULL
,	NULL
ZIIIA	NULL
,	NULL
or	NULL
ZIIIB	NULL
,	NULL
or	NULL
the	NULL
AP-1	NULL
octamer	NULL
sequence	NULL
.	NULL

Only	NULL
the	NULL
probe	NULL
that	NULL
was	NULL
shifted	NULL
by	NULL
binding	NULL
to	NULL
protein	NULL
is	NULL
shown	NULL
.	NULL

that	NULL
seen	NULL
with	NULL
the	NULL
CMV	NULL
vector	NULL
alone	NULL
with	NULL
BMRF1-CAT	NULL
.	NULL

CAT	NULL
assays	NULL
were	NULL
performed	NULL
in	NULL
four	NULL
separate	NULL
transfection	NULL
experiments	NULL
.	NULL

RNA	NULL
preparation	NULL
and	NULL
Northern	NULL
blotting	NULL
.	NULL

Cytoplasmic	NULL
RNA	NULL
was	NULL
prepared	NULL
from	NULL
3	NULL
X	NULL
10Â°	NULL
cells	NULL
20	NULL
h	NULL
after	NULL
transfection	NULL
and	NULL
subjected	NULL
to	NULL
Northern	NULL
blotting	NULL
according	NULL
to	NULL
published	NULL
methods	NULL
(	NULL
30	NULL
)	NULL
.	NULL

Blots	NULL
were	NULL
probed	NULL
with	NULL
a	NULL
531-bp	NULL
Eagl	NULL
restriction	NULL
fragment	NULL
of	NULL
DNA	NULL
containing	NULL
sequences	NULL
from	NULL
the	NULL
BMRF1	NULL
and	NULL
BaRF1	NULL
genes	NULL
(	NULL
EBV	NULL
genomic	NULL
sequence	NULL
80141	NULL
to	NULL
80672	NULL
)	NULL
and	NULL
a	NULL
370-bp	NULL
Ncol-to-Psfl	NULL
restriction	NULL
fragment	NULL
from	NULL
the	NULL
cDNA	NULL
for	NULL
the	NULL
H1	NULL
RNA	NULL
component	NULL
of	NULL
human	NULL
RNase	NULL
P	NULL
(	NULL
3	NULL
)	NULL
.	NULL

The	NULL
blot	NULL
was	NULL
reprobed	NULL
with	NULL
a	NULL
720-bp	NULL
Teql-to-Sa/l	NULL
fragment	NULL
of	NULL
the	NULL
BRLF1	NULL
gene	NULL
(	NULL
EBV	NULL
genomic	NULL
sequence	NULL
104577	NULL
to	NULL
105297	NULL
)	NULL
.	NULL

Probes	NULL
were	NULL
random-prime	NULL
labelled	NULL
with	NULL
[	NULL
Â«	NULL
-*	NULL
``	NULL
P	NULL
]	NULL
dCTP	NULL
and	NULL
Klenow	NULL
enzyme	NULL
(	NULL
Boehringer	NULL
Mannheim	NULL
}	NULL
.	NULL

RESULTS	NULL
DNA	NULL
binding	NULL
by	NULL
ZEBRA	NULL
and	NULL
basic-domain	NULL
mutant	NULL
proteins	NULL
.	NULL

The	NULL
effect	NULL
of	NULL
substitution	NULL
of	NULL
alanine	NULL
for	NULL
serine	NULL
at	NULL
position	NULL
186	NULL
in	NULL
the	NULL
DNA-binding	NULL
domain	NULL
of	NULL
ZEBRA	NULL
was	NULL
studied	NULL
by	NULL
electrophoretic	NULL
mobility	NULL
shift	NULL
assays	NULL
(	NULL
EMSAs	NULL
)	NULL
.	NULL

BL21	NULL
(	NULL
DE3	NULL
)	NULL
bacterial	NULL
extracts	NULL
containing	NULL
overexpressed	NULL
ZEBRA	NULL
,	NULL
Z	NULL
(	NULL
S186A	NULL
)	NULL
,	NULL
or	NULL
ZFZ	NULL
(	NULL
which	NULL
contains	NULL
a	NULL
substitution	NULL
of	NULL
the	NULL
basic	NULL
domain	NULL
of	NULL
ZEBRA	NULL
for	NULL
that	NULL
of	NULL
c-Fos	NULL
[	NULL
30	NULL
]	NULL
)	NULL
or	NULL
pET11d	NULL
vector	NULL
alone	NULL
were	NULL
assessed	NULL
for	NULL
their	NULL
ability	NULL
to	NULL
shift	NULL
oligonucleotide	NULL
probes	NULL
containing	NULL
three	NULL
known	NULL
ZEBRA	NULL
binding	NULL
sites	NULL
and	NULL
an	NULL
AP-1	NULL
octamer	NULL
site	NULL
(	NULL
TRE	NULL
)	NULL
.	NULL

Protein	NULL
extracts	NULL
were	NULL
incubated	NULL
with	NULL
Â°Â°P-labelled	NULL
27-mer	NULL
duplex	NULL
oligonucleotides	NULL
harboring	NULL
either	NULL
a	NULL
ZRE-R	NULL
,	NULL
ZIIIA	NULL
,	NULL
or	NULL
ZIIIB	NULL
site	NULL
or	NULL
a	NULL
28-mer	NULL
containing	NULL
an	NULL
AP-1	NULL
octamer	NULL
site	NULL
.	NULL

No	NULL
bacterial	NULL
proteins	NULL
present	NULL
in	NULL
E.	NULL
coli	NULL
BL21	NULL
(	NULL
DE3	NULL
)	NULL
were	NULL
able	NULL
to	NULL
shift	NULL
any	NULL
of	NULL
the	NULL
oligonucleotide	NULL
probes	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
,	NULL
lane	NULL
1	NULL
)	NULL
.	NULL

As	NULL
expected	NULL
,	NULL
ZEBRA	NULL
shifted	NULL
ZRE	NULL
probes	NULL
(	NULL
ZRE-R	NULL
,	NULL
ZIIIA	NULL
,	NULL
and	NULL
ZIIIB	NULL
)	NULL
very	NULL
efficiently	NULL
but	NULL
bound	NULL
poorly	NULL
to	NULL
an	NULL
AP-1	NULL
octamer	NULL
site	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
,	NULL
lane	NULL
2	NULL
)	NULL
.	NULL

The	NULL
Z	NULL
(	NULL
S186AÂ¥	NULL
)	NULL
mutant	NULL
recognized	NULL
all	NULL
ZRE	NULL
probes	NULL
and	NULL
,	NULL
in	NULL
addition	NULL
,	NULL
produced	NULL
a	NULL
shifted	NULL
band	NULL
of	NULL
greater	NULL
intensity	NULL
than	NULL
wild-type	NULL
ZEBRA	NULL
on	NULL
an	NULL
AP-1	NULL
octamer	NULL
probe	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
,	NULL
lane	NULL
3	NULL
)	NULL
.	NULL

The	NULL
ZEBRA/Fos	NULL
chimeric	NULL
protein	NULL
ZFZ	NULL
bound	NULL
poorly	NULL
to	NULL
ZRE-R	NULL
and	NULL
ZIIIB	NULL
probes	NULL
,	NULL
somewhat	NULL
better	NULL
to	NULL
the	NULL
ZIIIA	NULL
site	NULL
,	NULL
which	NULL
J.	NULL
ViRoL	NULL
.	NULL

more	NULL
closely	NULL
resembles	NULL
an	NULL
AP-1	NULL
site	NULL
,	NULL
and	NULL
very	NULL
efficiently	NULL
to	NULL
an	NULL
AP-1	NULL
octamer	NULL
site	NULL
.	NULL

Comparison	NULL
of	NULL
affinities	NULL
of	NULL
ZEBRA	NULL
and	NULL
Z	NULL
(	NULL
S186A	NULL
)	NULL
.	NULL

A	NULL
method	NULL
of	NULL
determining	NULL
the	NULL
relative	NULL
affinities	NULL
of	NULL
ZEBRA	NULL
and	NULL
Z	NULL
(	NULL
S186A	NULL
)	NULL
for	NULL
ZREs	NULL
involved	NULL
subjecting	NULL
both	NULL
ZEBRA	NULL
and	NULL
Z	NULL
(	NULL
S186A	NULL
)	NULL
binding	NULL
complexes	NULL
to	NULL
competition	NULL
with	NULL
increasing	NULL
amounts	NULL
of	NULL
the	NULL
same	NULL
competitor	NULL
DNA-binding	NULL
protein	NULL
,	NULL
ZA131	NULL
.	NULL

This	NULL
truncation	NULL
mutant	NULL
,	NULL
lacking	NULL
the	NULL
N-terminal	NULL
131	NULL
amino	NULL
acids	NULL
of	NULL
the	NULL
protein	NULL
,	NULL
still	NULL
bound	NULL
to	NULL
DNA	NULL
efficiently	NULL
but	NULL
produced	NULL
a	NULL
shifted	NULL
complex	NULL
with	NULL
much	NULL
faster	NULL
mobility	NULL
than	NULL
ZEBRA	NULL
or	NULL
Z	NULL
(	NULL
S186A	NULL
)	NULL
on	NULL
6	NULL
%	NULL
acrylamide	NULL
native	NULL
gels	NULL
.	NULL

Therefore	NULL
,	NULL
a	NULL
reaction	NULL
mixture	NULL
containing	NULL
ZA131	NULL
and	NULL
Z	NULL
(	NULL
S186A	NULL
)	NULL
as	NULL
well	NULL
as	NULL
labeled	NULL
ZRE	NULL
probe	NULL
produced	NULL
two	NULL
shifted	NULL
bands	NULL
after	NULL
electrophoretic	NULL
separation	NULL
,	NULL
with	NULL
the	NULL
upper	NULL
complex	NULL
containing	NULL
Z	NULL
(	NULL
S186A	NULL
)	NULL
-shifted	NULL
probe	NULL
and	NULL
the	NULL
band	NULL
of	NULL
faster	NULL
mobility	NULL
containing	NULL
ZA131-shifted	NULL
probe	NULL
.	NULL

A	NULL
shifted	NULL
product	NULL
with	NULL
intermediate	NULL
mobility	NULL
,	NULL
representing	NULL
Z	NULL
(	NULL
S186A	NULL
)	NULL
-ZA131	NULL
heterodimers	NULL
,	NULL
was	NULL
not	NULL
apparent	NULL
;	NULL
past	NULL
experiments	NULL
suggest	NULL
that	NULL
dimerization	NULL
partner	NULL
exchange	NULL
is	NULL
unlikely	NULL
to	NULL
occur	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
denaturing	NULL
agents	NULL
such	NULL
as	NULL
urea	NULL
.	NULL

When	NULL
binding	NULL
reactions	NULL
containing	NULL
ZEBRA	NULL
or	NULL
Z	NULL
(	NULL
S186A	NULL
)	NULL
and	NULL
labelled	NULL
ZRE2	NULL
probe	NULL
were	NULL
challenged	NULL
with	NULL
increasing	NULL
amounts	NULL
of	NULL
ZA131	NULL
extract	NULL
,	NULL
the	NULL
intensity	NULL
of	NULL
ZEBRA-	NULL
or	NULL
Z	NULL
(	NULL
S186A	NULL
)	NULL
-shifted	NULL
probe	NULL
decreased	NULL
and	NULL
the	NULL
intensity	NULL
of	NULL
the	NULL
band	NULL
representing	NULL
ZA131-shifted	NULL
probe	NULL
increased	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
.	NULL

Quantitation	NULL
of	NULL
the	NULL
percentage	NULL
of	NULL
total	NULL
probe	NULL
present	NULL
in	NULL
each	NULL
complex	NULL
showed	NULL
that	NULL
ZA131	NULL
competed	NULL
with	NULL
ZEBRA	NULL
and	NULL
with	NULL
Z	NULL
(	NULL
S186A	NULL
)	NULL
in	NULL
an	NULL
identical	NULL
manner	NULL
.	NULL

For	NULL
ex-ample	NULL
,	NULL
after	NULL
the	NULL
addition	NULL
of	NULL
0.5	NULL
ul	NULL
of	NULL
ZA131	NULL
extract	NULL
to	NULL
either	NULL
PROBE	NULL
:	NULL
ZRE2	NULL
(	NULL
TGAGCAA	NULL
)	NULL
PROTEIN	NULL
:	NULL
ZEBRA	NULL
Z	NULL
(	NULL
S186A	NULL
)	NULL
ZA131	NULL
(	NULL
ul	NULL
)	NULL
W	NULL
|	NULL
0.5	NULL
I	NULL
1.0	NULL
|	NULL
so	NULL
IL	NULL
l	NULL
0.5	NULL
|	NULL
1.0	NULL
I	NULL
2.0	NULL
tlt2a2's't	NULL
``	NULL
a8	NULL
,	NULL
``	NULL
7	NULL
8,2	NULL
?	NULL

ZEBRA	NULL
.	NULL

AND	NULL
-	NULL
-	NULL
Â»	NULL
Z	NULL
(	NULL
S186A	NULL
)	NULL
.-.~	NULL
â	NULL
--	NULL
ZM31	NULL
-	NULL
Â»	NULL
lee	NULL
am	NULL
tay	NULL
=	NULL
\ew	NULL
an	NULL
tal	NULL
FREE	NULL
h.	NULL
â	NULL
.~	NULL
%	NULL
PROBE	NULL
SHIFTED	NULL
:	NULL
ZEBRA	NULL
ss	NULL
|	NULL
sof	NULL
25	NULL
|	NULL
16	NULL
Z	NULL
(	NULL
S186A	NULL
)	NULL
49	NULL
[	NULL
33	NULL
J	NULL
22	NULL
|	NULL
13	NULL
ZM31	NULL
32	NULL
)	NULL
as	NULL
|	NULL
58	NULL
32	NULL
|	NULL
47	NULL
|	NULL
61	NULL
FIG	NULL
.	NULL

3	NULL
.	NULL

EMSA	NULL
showing	NULL
competition	NULL
of	NULL
ZEBRA	NULL
and	NULL
Z	NULL
(	NULL
S186A	NULL
)	NULL
with	NULL
ZA131	NULL
on	NULL
an	NULL
oligonucleotide	NULL
probe	NULL
containing	NULL
a	NULL
ZRE2	NULL
site	NULL
.	NULL

The	NULL
binding	NULL
of	NULL
ZEBRA	NULL
and	NULL
Z	NULL
(	NULL
S186A	NULL
)	NULL
is	NULL
assessed	NULL
alone	NULL
(	NULL
lanes	NULL
2	NULL
and	NULL
6	NULL
)	NULL
and	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
increasing	NULL
amounts	NULL
of	NULL
ZA131	NULL
extract	NULL
(	NULL
0.5	NULL
,	NULL
1	NULL
,	NULL
or	NULL
2	NULL
pl	NULL
)	NULL
.	NULL

The	NULL
proportion	NULL
of	NULL
the	NULL
labelled	NULL
probe	NULL
that	NULL
was	NULL
unbound	NULL
or	NULL
was	NULL
bound	NULL
by	NULL
each	NULL
protein	NULL
was	NULL
quantitated	NULL
by	NULL
phosphorimage	NULL
analysis	NULL
.	NULL

The	NULL
percentages	NULL
of	NULL
the	NULL
total	NULL
labelled	NULL
probe	NULL
that	NULL
were	NULL
bound	NULL
by	NULL
the	NULL
various	NULL
proteins	NULL
are	NULL
indicated	NULL
below	NULL
the	NULL
gel	NULL
,	NULL
with	NULL
the	NULL
boldface	NULL
boxes	NULL
indicating	NULL
the	NULL
point	NULL
at	NULL
which	NULL
ZA131	NULL
shifts	NULL
approximately	NULL
the	NULL
same	NULL
amount	NULL
of	NULL
probe	NULL
as	NULL
ZEBRA	NULL
or	NULL
Z	NULL
(	NULL
S186A	NULL
)	NULL
.	NULL

Vor	NULL
.	NULL

71	NULL
,	NULL
1997	NULL
BJAB	NULL
gZVP	NULL
[	NULL
OC	NULL
]	NULL
m	NULL
<	NULL
hast	NULL
Â«	NULL
1B	NULL
.E	NULL
.E	NULL
$	NULL
2	NULL
>	NULL
>	NULL
&	NULL
2	NULL
Â§os	NULL
Â§	NULL
s	NULL
5m	NULL
i	NULL
n	NULL
Â©	NULL
m	NULL
O	NULL
m	NULL
O	NULL
m	NULL
a	NULL
N	NULL
o	NULL
Markers	NULL
(	NULL
kDa	NULL
)	NULL
ZVP	NULL
-	NULL
aao	NULL
_	NULL
Wit	NULL
=	NULL
Wie	NULL
-	NULL
50	NULL
ZEBRA	NULL
-	NULL
Â«	NULL
Â»	NULL
Â»	NULL
wo	NULL
-	NULL
W	NULL
-	NULL
35.0	NULL
1	NULL
2	NULL
8	NULL
40	NULL
50	NULL
60	NULL
7	NULL
8	NULL
9	NULL
SERUM	NULL
:	NULL
ANTI-BZLF1	NULL
FIG	NULL
.	NULL

4	NULL
.	NULL

Expression	NULL
of	NULL
transfected	NULL
ZEBRA	NULL
and	NULL
Z	NULL
(	NULL
S	NULL
$	NULL
186A	NULL
)	NULL
constructs	NULL
.	NULL

Shown	NULL
is	NULL
a	NULL
Western	NULL
blot	NULL
exhibiting	NULL
expression	NULL
of	NULL
the	NULL
proteins	NULL
ZEBRA	NULL
and	NULL
Z	NULL
(	NULL
S186A	NULL
)	NULL
in	NULL
BJAB	NULL
cells	NULL
with	NULL
respect	NULL
to	NULL
that	NULL
of	NULL
a	NULL
cotransfected	NULL
reference	NULL
ZEBRA-VP16	NULL
fusion	NULL
protein	NULL
,	NULL
gZ	NULL
(	NULL
1-227	NULL
)	NULL
+	NULL
VP16	NULL
(	NULL
ZVP	NULL
)	NULL
.	NULL

BJAB	NULL
cells	NULL
were	NULL
cotransfected	NULL
with	NULL
10	NULL
ug	NULL
of	NULL
either	NULL
genomic	NULL
ZEBRA	NULL
(	NULL
g2Z	NULL
)	NULL
(	NULL
lane	NULL
7	NULL
)	NULL
,	NULL
gZ	NULL
(	NULL
$	NULL
186A	NULL
)	NULL
(	NULL
lane	NULL
9	NULL
)	NULL
,	NULL
or	NULL
CMV	NULL
vector	NULL
(	NULL
lane	NULL
5	NULL
)	NULL
and	NULL
10	NULL
ug	NULL
of	NULL
ZVP	NULL
.	NULL

BJAB	NULL
cells	NULL
transfected	NULL
with	NULL
20	NULL
ug	NULL
of	NULL
CMV	NULL
vector	NULL
without	NULL
ZVP	NULL
were	NULL
included	NULL
in	NULL
lane	NULL
3	NULL
.	NULL

P3J-HR-1	NULL
clone	NULL
16	NULL
cells	NULL
induced	NULL
with	NULL
TPA	NULL
and	NULL
sodium	NULL
butyrate	NULL
(	NULL
cl	NULL
.	NULL

16	NULL
+	NULL
T/B	NULL
)	NULL
served	NULL
as	NULL
a	NULL
positive	NULL
control	NULL
for	NULL
detection	NULL
of	NULL
the	NULL
ZEBRA	NULL
protein	NULL
(	NULL
lane	NULL
1	NULL
)	NULL
.	NULL

Whole-cell	NULL
lysates	NULL
from	NULL
these	NULL
cells	NULL
were	NULL
separated	NULL
by	NULL
SDS-PAGE	NULL
,	NULL
probed	NULL
with	NULL
monospecific	NULL
BZLF1	NULL
antiserum	NULL
,	NULL
and	NULL
reacted	NULL
with	NULL
*	NULL
``	NULL
I-protein	NULL
A.	NULL
the	NULL
ZEBRA	NULL
or	NULL
Z	NULL
(	NULL
S186A	NULL
)	NULL
binding	NULL
reactions	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
,	NULL
lanes	NULL
3	NULL
and	NULL
7	NULL
)	NULL
,	NULL
approximately	NULL
30	NULL
%	NULL
of	NULL
the	NULL
total	NULL
probe	NULL
was	NULL
present	NULL
in	NULL
each	NULL
of	NULL
the	NULL
shifted	NULL
complexes	NULL
[	NULL
ZEBRA	NULL
,	NULL
Z	NULL
(	NULL
S186A	NULL
)	NULL
,	NULL
and	NULL
ZA131	NULL
]	NULL
.	NULL

Therefore	NULL
,	NULL
ZEBRA	NULL
and	NULL
Z	NULL
(	NULL
S186A	NULL
)	NULL
had	NULL
the	NULL
same	NULL
Z	NULL
(	NULL
S1B6A	NULL
)	NULL
FAILS	NULL
TO	NULL
DISRUPT	NULL
LATENCY	NULL
_	NULL
3057	NULL
affinity	NULL
for	NULL
the	NULL
ZRE2	NULL
oligonucleotide	NULL
probe	NULL
compared	NULL
to	NULL
ZA131	NULL
.	NULL

Expression	NULL
of	NULL
transfected	NULL
ZEBRA	NULL
and	NULL
Z	NULL
(	NULL
S	NULL
$	NULL
186A	NULL
)	NULL
constructs	NULL
in	NULL
human	NULL
B	NULL
lymphocytes	NULL
.	NULL

Protein	NULL
expression	NULL
from	NULL
the	NULL
BZLF1	NULL
cDNA	NULL
and	NULL
that	NULL
from	NULL
the	NULL
genomic	NULL
sequence	NULL
which	NULL
contains	NULL
two	NULL
introns	NULL
were	NULL
compared	NULL
in	NULL
preliminary	NULL
experiments	NULL
.	NULL

Genomic	NULL
constructs	NULL
of	NULL
ZEBRA	NULL
(	NULL
gZ	NULL
)	NULL
were	NULL
expressed	NULL
more	NULL
abundantly	NULL
than	NULL
the	NULL
cDNA	NULL
in	NULL
human	NULL
B	NULL
cell	NULL
lines	NULL
(	NULL
1	NULL
)	NULL
.	NULL

For	NULL
this	NULL
reason	NULL
,	NULL
mutations	NULL
at	NULL
amino	NULL
acid	NULL
186	NULL
were	NULL
studied	NULL
in	NULL
the	NULL
context	NULL
of	NULL
genomic	NULL
ZEBRA	NULL
for	NULL
all	NULL
B-cell	NULL
experiments	NULL
.	NULL

To	NULL
determine	NULL
if	NULL
the	NULL
S	NULL
$	NULL
186A	NULL
substitution	NULL
caused	NULL
altered	NULL
expression	NULL
in	NULL
mammalian	NULL
cells	NULL
compared	NULL
with	NULL
wild-type	NULL
ZEBRA	NULL
,	NULL
CMV	NULL
IE	NULL
promoter-driven	NULL
genomic	NULL
constructs	NULL
of	NULL
ZEBRA	NULL
or	NULL
Z	NULL
(	NULL
S186A	NULL
)	NULL
were	NULL
cotransfected	NULL
with	NULL
Z	NULL
(	NULL
1-227	NULL
+	NULL
VP16	NULL
)	NULL
(	NULL
ZVP	NULL
)	NULL
into	NULL
the	NULL
EBV-negative	NULL
BJAB	NULL
cell	NULL
line	NULL
.	NULL

ZVP	NULL
served	NULL
as	NULL
a	NULL
tagged	NULL
reference	NULL
protein	NULL
with	NULL
slower	NULL
mobility	NULL
than	NULL
ZEBRA	NULL
and	NULL
Z	NULL
(	NULL
S186A	NULL
)	NULL
to	NULL
which	NULL
expression	NULL
of	NULL
other	NULL
constructs	NULL
was	NULL
standardized	NULL
.	NULL

Three	NULL
days	NULL
after	NULL
transfection	NULL
,	NULL
protein	NULL
extracts	NULL
were	NULL
immunoblotted	NULL
with	NULL
antiserum	NULL
raised	NULL
against	NULL
ZEBRA	NULL
that	NULL
recognized	NULL
all	NULL
three	NULL
proteins	NULL
,	NULL
ZEBRA	NULL
,	NULL
Z	NULL
(	NULL
S186A	NULL
)	NULL
,	NULL
and	NULL
ZVP	NULL
.	NULL

The	NULL
ZVP	NULL
protein	NULL
was	NULL
expressed	NULL
at	NULL
similar	NULL
levels	NULL
in	NULL
all	NULL
transfections	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
the	NULL
ZEBRA	NULL
and	NULL
Z	NULL
(	NULL
S186A	NULL
)	NULL
proteins	NULL
were	NULL
expressed	NULL
at	NULL
identical	NULL
levels	NULL
when	NULL
compared	NULL
to	NULL
the	NULL
coexpressed	NULL
ZVP	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
,	NULL
compare	NULL
lanes	NULL
7	NULL
and	NULL
9	NULL
)	NULL
,	NULL
a	NULL
result	NULL
that	NULL
was	NULL
confirmed	NULL
by	NULL
quantitation	NULL
of	NULL
bands	NULL
by	NULL
phosphorimage	NULL
analysis	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

This	NULL
result	NULL
indicated	NULL
that	NULL
the	NULL
S186	NULL
mutation	NULL
did	NULL
not	NULL
affect	NULL
protein	NULL
expression	NULL
in	NULL
EBV-negative	NULL
B	NULL
cells	NULL
.	NULL

Abilities	NULL
of	NULL
ZEBRA	NULL
and	NULL
Z	NULL
(	NULL
S186A	NULL
)	NULL
to	NULL
activate	NULL
transcription	NULL
of	NULL
reporter	NULL
constructs	NULL
containing	NULL
early	NULL
lytic	NULL
viral	NULL
promoters	NULL
.	NULL

CMV	NULL
IE	NULL
promoter-driven	NULL
genomic	NULL
constructs	NULL
of	NULL
ZEBRA	NULL
or	NULL
Z	NULL
(	NULL
S186A	NULL
)	NULL
were	NULL
transfected	NULL
into	NULL
EBV-negative	NULL
BJAB	NULL
cells	NULL
together	NULL
with	NULL
a	NULL
333-bp	NULL
region	NULL
of	NULL
the	NULL
early	NULL
viral	NULL
lytic	NULL
cycle	NULL
pro	NULL
RRE	NULL
AP-1	NULL
ZRE2	NULL
AP-1	NULL
-	NULL
ZRE2	NULL
Iâ	NULL
>	NULL
A-+-tC	NULL
--	NULL
-O	NULL
--	NULL
G	NULL
0-G	NULL
-333	NULL
172/156	NULL
139/133	NULL
~112/-105	NULL
-65/-59	NULL
-	NULL
-48/-42	NULL
+1	NULL
(	NULL
79.537	NULL
)	NULL
(	NULL
79,870	NULL
)	NULL
BamH	NULL
|	NULL
Asa	NULL
|	NULL
B	NULL
)	NULL
_	NULL
REPORTER	NULL
:	NULL
BMRF1p-CAT	NULL
(	NULL
5ug	NULL
)	NULL
|	NULL
|	NULL
ACTIVATOR	NULL
:	NULL
CMV	NULL
gZ	NULL
gZ	NULL
(	NULL
S186A	NULL
)	NULL
[	NULL
Ml	NULL
I	NULL
10ug	NULL
0.1iug	NULL
1.0ug	NULL
10ug	NULL
O0.iug	NULL
1.0ug	NULL
_	NULL
10ug	NULL
CELL	NULL
LINE	NULL
:	NULL
BJAB	NULL
%	NULL
ACETYLATION	NULL
:	NULL
0.28	NULL
8	NULL
12	NULL
STIMULATION	NULL
:	NULL
28X	NULL
1	NULL
2	NULL
3	NULL
43X	NULL
11	NULL
8	NULL
28	NULL
35	NULL
39X	NULL
_	NULL
28	NULL
%	NULL
100	NULL
%	NULL
__	NULL
125	NULL
%	NULL
4	NULL
5	NULL
6	NULL
7	NULL
FIG	NULL
.	NULL

5	NULL
.	NULL

Comparison	NULL
of	NULL
transcriptional	NULL
activation	NULL
by	NULL
ZEBRA	NULL
and	NULL
Z	NULL
(	NULL
S186A	NULL
)	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Location	NULL
of	NULL
AP-1	NULL
sites	NULL
,	NULL
ZREs	NULL
,	NULL
and	NULL
Rta	NULL
response	NULL
elements	NULL
(	NULL
RREs	NULL
)	NULL
in	NULL
the	NULL
333-bp	NULL
fragment	NULL
of	NULL
the	NULL
BMRF1	NULL
promoter	NULL
from	NULL
EBV	NULL
in	NULL
BMRFip-CAT	NULL
(	NULL
39	NULL
)	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Representative	NULL
data	NULL
showing	NULL
CAT	NULL
activity	NULL
in	NULL
BJAB	NULL
cells	NULL
cotransfected	NULL
with	NULL
BMRF1p-CAT	NULL
(	NULL
5	NULL
mg	NULL
)	NULL
and	NULL
CMV	NULL
vector	NULL
(	NULL
10	NULL
pg	NULL
)	NULL
or	NULL
increasing	NULL
amounts	NULL
(	NULL
0.1	NULL
,	NULL
1.0	NULL
,	NULL
or	NULL
10	NULL
ug	NULL
)	NULL
of	NULL
genomic	NULL
ZEBRA	NULL
(	NULL
gZ	NULL
)	NULL
(	NULL
lanes	NULL
2	NULL
to	NULL
4	NULL
,	NULL
respectively	NULL
)	NULL
or	NULL
gZ	NULL
(	NULL
S186A	NULL
)	NULL
(	NULL
lanes	NULL
5	NULL
to	NULL
7	NULL
,	NULL
respectively	NULL
)	NULL
.	NULL

3058	NULL
FRANCIS	NULL
ET	NULL
AL	NULL
.	NULL

moter	NULL
BMRF1	NULL
that	NULL
was	NULL
cloned	NULL
upstream	NULL
of	NULL
the	NULL
CAT	NULL
gene	NULL
.	NULL

While	NULL
transfection	NULL
of	NULL
the	NULL
CMV	NULL
vector	NULL
alone	NULL
led	NULL
to	NULL
little	NULL
background	NULL
chloramphenicol	NULL
acetylation	NULL
,	NULL
transfection	NULL
of	NULL
0.1	NULL
ug	NULL
of	NULL
ZEBRA	NULL
or	NULL
Z	NULL
(	NULL
S186A	NULL
)	NULL
was	NULL
able	NULL
to	NULL
activate	NULL
transcription	NULL
of	NULL
this	NULL
reporter	NULL
at	NULL
levels	NULL
28-fold	NULL
greater	NULL
than	NULL
background	NULL
in	NULL
BJAB	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
)	NULL
.	NULL

In	NULL
fact	NULL
,	NULL
at	NULL
inputs	NULL
of	NULL
1	NULL
and	NULL
10	NULL
pg	NULL
of	NULL
plasmid	NULL
DNA	NULL
,	NULL
Z	NULL
(	NULL
S186A	NULL
)	NULL
expression	NULL
led	NULL
to	NULL
two	NULL
to	NULL
three	NULL
times	NULL
higher	NULL
stimulation	NULL
of	NULL
CAT	NULL
activity	NULL
than	NULL
did	NULL
the	NULL
wild-type	NULL
ZEBRA	NULL
protein	NULL
(	NULL
approximately	NULL
100-fold	NULL
compared	NULL
to	NULL
40-fold	NULL
[	NULL
Fig	NULL
.	NULL

5	NULL
,	NULL
compare	NULL
lanes	NULL
3	NULL
and	NULL
6	NULL
and	NULL
lanes	NULL
4	NULL
and	NULL
7	NULL
]	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
substitution	NULL
of	NULL
alanine	NULL
at	NULL
amino	NULL
acid	NULL
186	NULL
enhanced	NULL
,	NULL
rather	NULL
than	NULL
diminished	NULL
,	NULL
the	NULL
ability	NULL
of	NULL
ZEBRA	NULL
to	NULL
promote	NULL
transcription	NULL
from	NULL
the	NULL
early	NULL
viral	NULL
lytic	NULL
cycle	NULL
promoter	NULL
BMRF1	NULL
in	NULL
the	NULL
context	NULL
of	NULL
a	NULL
reporter	NULL
construct	NULL
in	NULL
BJAB	NULL
cells	NULL
.	NULL

Capacities	NULL
of	NULL
ZEBRA	NULL
and	NULL
Z	NULL
(	NULL
S186A	NULL
)	NULL
to	NULL
disrupt	NULL
latency	NULL
of	NULL
EBV	NULL
.	NULL

The	NULL
ZEBRA	NULL
protein	NULL
has	NULL
the	NULL
capacity	NULL
to	NULL
induce	NULL
lytic	NULL
cycle	NULL
expression	NULL
of	NULL
EBV	NULL
in	NULL
several	NULL
latently	NULL
infected	NULL
cell	NULL
lines	NULL
.	NULL

This	NULL
disruption	NULL
of	NULL
latency	NULL
can	NULL
be	NULL
monitored	NULL
by	NULL
assessing	NULL
the	NULL
expression	NULL
of	NULL
lytic	NULL
products	NULL
at	NULL
the	NULL
RNA	NULL
or	NULL
protein	NULL
level	NULL
.	NULL

We	NULL
therefore	NULL
examined	NULL
the	NULL
abilities	NULL
of	NULL
transfected	NULL
ZEBRA	NULL
and	NULL
Z	NULL
(	NULL
S186A	NULL
)	NULL
to	NULL
induce	NULL
the	NULL
appearance	NULL
of	NULL
early	NULL
lytic	NULL
cycle	NULL
transcripts	NULL
in	NULL
Raji	NULL
cells	NULL
,	NULL
which	NULL
contain	NULL
a	NULL
latent	NULL
EBV	NULL
genome	NULL
,	NULL
by	NULL
Northern	NULL
analysis	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
)	NULL
.	NULL

Transfection	NULL
of	NULL
Raji	NULL
cells	NULL
with	NULL
increasing	NULL
amounts	NULL
of	NULL
a	NULL
ZEBRA	NULL
expression	NULL
construct	NULL
led	NULL
to	NULL
corresponding	NULL
increases	NULL
in	NULL
the	NULL
levels	NULL
of	NULL
two	NULL
viral	NULL
mRNAs	NULL
known	NULL
to	NULL
be	NULL
induced	NULL
during	NULL
the	NULL
lytic	NULL
phase	NULL
(	NULL
Fig	NULL
.	NULL

6A	NULL
)	NULL
:	NULL
the	NULL
3.6-kb	NULL
BaRF1l	NULL
mRNA	NULL
,	NULL
whose	NULL
product	NULL
is	NULL
a	NULL
component	NULL
of	NULL
ribo-nucleotide	NULL
reductase	NULL
,	NULL
and	NULL
the	NULL
2.5-kb	NULL
BMRF1	NULL
mRNA	NULL
,	NULL
which	NULL
encodes	NULL
a	NULL
DNA	NULL
polymerase	NULL
accessory	NULL
factor	NULL
originally	NULL
described	NULL
as	NULL
diffuse	NULL
early	NULL
antigen	NULL
EA-D	NULL
(	NULL
7	NULL
,	NULL
38	NULL
)	NULL
.	NULL

However	NULL
,	NULL
despite	NULL
the	NULL
ability	NULL
of	NULL
Z	NULL
(	NULL
S186A	NULL
)	NULL
to	NULL
activate	NULL
the	NULL
BMRF1	NULL
promoter	NULL
in	NULL
a	NULL
CAT	NULL
assay	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
)	NULL
,	NULL
transfection	NULL
of	NULL
Raji	NULL
cells	NULL
with	NULL
Z	NULL
(	NULL
S186AÂ¥	NULL
)	NULL
did	NULL
not	NULL
lead	NULL
to	NULL
detectable	NULL
BMRF1	NULL
or	NULL
BaRF1	NULL
transcription	NULL
from	NULL
the	NULL
intact	NULL
viral	NULL
genome	NULL
(	NULL
Fig	NULL
.	NULL

6A	NULL
,	NULL
lanes	NULL
6	NULL
to	NULL
8	NULL
)	NULL
.	NULL

Additionally	NULL
,	NULL
Z	NULL
(	NULL
S186A	NULL
)	NULL
expression	NULL
did	NULL
not	NULL
result	NULL
in	NULL
transcription	NULL
of	NULL
the	NULL
immediate-early	NULL
viral	NULL
BRLF1	NULL
mRNA	NULL
,	NULL
which	NULL
is	NULL
the	NULL
first	NULL
known	NULL
message	NULL
induced	NULL
after	NULL
entry	NULL
into	NULL
the	NULL
lytic	NULL
cycle	NULL
(	NULL
Fig	NULL
.	NULL

6B	NULL
)	NULL
.	NULL

The	NULL
abundance	NULL
of	NULL
the	NULL
ubiquitously	NULL
expressed	NULL
H1	NULL
RNA	NULL
component	NULL
of	NULL
RNase	NULL
P	NULL
indicated	NULL
that	NULL
the	NULL
same	NULL
amount	NULL
of	NULL
cellular	NULL
RNA	NULL
was	NULL
loaded	NULL
in	NULL
each	NULL
lane	NULL
(	NULL
Fig	NULL
.	NULL

6C	NULL
)	NULL
.	NULL

Therefore	NULL
,	NULL
changing	NULL
the	NULL
serine	NULL
at	NULL
position	NULL
186	NULL
of	NULL
the	NULL
ZEBRA	NULL
protein	NULL
to	NULL
an	NULL
alanine	NULL
completely	NULL
destroyed	NULL
its	NULL
ability	NULL
to	NULL
promote	NULL
the	NULL
entry	NULL
of	NULL
EBV	NULL
into	NULL
the	NULL
lytic	NULL
cycle	NULL
in	NULL
Raji	NULL
cells	NULL
.	NULL

Identical	NULL
results	NULL
were	NULL
obtained	NULL
in	NULL
another	NULL
cell	NULL
line	NULL
containing	NULL
a	NULL
latent	NULL
EBV	NULL
genome	NULL
,	NULL
P3J-HR-1	NULL
clone	NULL
16	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Simultaneous	NULL
assessment	NULL
of	NULL
transcriptional	NULL
activation	NULL
and	NULL
disruption	NULL
of	NULL
latency	NULL
.	NULL

The	NULL
apparent	NULL
paradox	NULL
presented	NULL
by	NULL
Z	NULL
(	NULL
S186A	NULL
)	NULL
's	NULL
ability	NULL
to	NULL
activate	NULL
a	NULL
lytic	NULL
cycle	NULL
promoter	NULL
in	NULL
a	NULL
reporter	NULL
construct	NULL
in	NULL
EBV-negative	NULL
cells	NULL
and	NULL
its	NULL
failure	NULL
to	NULL
induce	NULL
lytic	NULL
cycle	NULL
transcription	NULL
from	NULL
the	NULL
virus	NULL
in	NULL
EBV-positive	NULL
cells	NULL
compelled	NULL
us	NULL
to	NULL
assess	NULL
these	NULL
functions	NULL
simultaneously	NULL
in	NULL
Raji	NULL
cells	NULL
.	NULL

Cells	NULL
were	NULL
transfected	NULL
with	NULL
BMRF1p-CAT	NULL
and	NULL
increasing	NULL
amounts	NULL
of	NULL
ZEBRA	NULL
,	NULL
Z	NULL
(	NULL
S186A	NULL
)	NULL
,	NULL
or	NULL
a	NULL
second	NULL
mutant	NULL
with	NULL
a	NULL
conservative	NULL
serine-to-threonine	NULL
substitution	NULL
at	NULL
position	NULL
186	NULL
,	NULL
Z	NULL
(	NULL
S186T	NULL
)	NULL
.	NULL

After	NULL
3	NULL
days	NULL
,	NULL
both	NULL
CAT	NULL
activity	NULL
and	NULL
lytic	NULL
cycle	NULL
protein	NULL
expression	NULL
were	NULL
measured	NULL
in	NULL
the	NULL
same	NULL
cell	NULL
extracts	NULL
.	NULL

In	NULL
Raji	NULL
cells	NULL
,	NULL
all	NULL
three	NULL
constructs	NULL
,	NULL
ZEBRA	NULL
,	NULL
Z	NULL
(	NULL
S186A	NULL
)	NULL
,	NULL
and	NULL
Z	NULL
(	NULL
S186T	NULL
)	NULL
,	NULL
very	NULL
efficiently	NULL
promoted	NULL
transcription	NULL
from	NULL
the	NULL
BMRF1	NULL
promoter	NULL
upstream	NULL
of	NULL
CAT	NULL
,	NULL
although	NULL
Z	NULL
(	NULL
S186A	NULL
)	NULL
had	NULL
the	NULL
most	NULL
potent	NULL
effect	NULL
on	NULL
CAT	NULL
activity	NULL
(	NULL
Fig	NULL
.	NULL

7A	NULL
)	NULL
.	NULL

Although	NULL
expression	NULL
from	NULL
the	NULL
ZEBRA	NULL
constructs	NULL
was	NULL
comparable	NULL
,	NULL
as	NULL
assessed	NULL
by	NULL
immunoblot	NULL
analysis	NULL
of	NULL
whole-cell	NULL
extracts	NULL
,	NULL
only	NULL
ZEBRA	NULL
and	NULL
Z	NULL
(	NULL
S186T	NULL
)	NULL
,	NULL
but	NULL
not	NULL
Z	NULL
(	NULL
S186A	NULL
)	NULL
,	NULL
induced	NULL
BMRF1L	NULL
protein	NULL
(	NULL
EA-D	NULL
)	NULL
expression	NULL
from	NULL
the	NULL
virus	NULL
(	NULL
Fig	NULL
.	NULL

7B	NULL
)	NULL
.	NULL

At	NULL
an	NULL
input	NULL
of	NULL
0.1	NULL
pg	NULL
of	NULL
the	NULL
ZEBRA	NULL
or	NULL
Z	NULL
(	NULL
S186T	NULL
)	NULL
expression	NULL
plas-mid	NULL
,	NULL
a	NULL
comparable	NULL
induction	NULL
of	NULL
EA-D	NULL
protein	NULL
was	NULL
observed	NULL
;	NULL
J.	NULL
ViRor	NULL
.	NULL

A	NULL
)	NULL
RAJI	NULL
Â°	NULL
|	NULL
toot	NULL
T	NULL
'	NULL
_	NULL
Ã©	NULL
oJ	NULL
,	NULL
__92._|	NULL
92	NULL
(	NULL
81864	NULL
)	NULL
_-	NULL
Markers	NULL
mRNAs	NULL
<	NULL
3	NULL
02	NULL
20	NULL
20	NULL
-	NULL
02	NULL
20	NULL
20	NULL
-	NULL
(	NULL
Kb	NULL
)	NULL
(	NULL
Kb	NULL
)	NULL
WYH	NULL
3.6	NULL
-	NULL
'	NULL
v	NULL
#	NULL
ag	NULL
BaRF1	NULL
__	NULL
2.5	NULL
-	NULL
\	NULL
-	NULL
agg	NULL
-	NULL
24	NULL
BMRF1	NULL
-	NULL
Â®	NULL
PROBE	NULL
:	NULL
BMRF1	NULL
22	NULL
,	NULL
:	NULL
P	NULL
B	NULL
)	NULL
gag	NULL
s.o	NULL
-|	NULL
IR	NULL
id	NULL
ti	NULL
RLF1	NULL
*	NULL
P	NULL
we	NULL
(	NULL
>	NULL
tant	NULL
tp	NULL
PROBE	NULL
:	NULL
BRLF1	NULL
c	NULL
)	NULL
oso	NULL
-	NULL
@	NULL
qaamem	NULL
cme	NULL
PROBE	NULL
:	NULL
RNase	NULL
P	NULL
FIG	NULL
.	NULL

6	NULL
.	NULL

Comparison	NULL
of	NULL
the	NULL
abilities	NULL
of	NULL
ZEBRA	NULL
and	NULL
Z	NULL
(	NULL
S186A	NULL
)	NULL
to	NULL
disrupt	NULL
latency	NULL
of	NULL
EBV	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Northern	NULL
analysis	NULL
of	NULL
BMRF1	NULL
and	NULL
BaRF1	NULL
transcripts	NULL
from	NULL
Raji	NULL
cells	NULL
transfected	NULL
with	NULL
genomic	NULL
ZEBRA	NULL
or	NULL
Z	NULL
(	NULL
S186A	NULL
)	NULL
.	NULL

Raji	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
CMV	NULL
vector	NULL
(	NULL
lane	NULL
3	NULL
)	NULL
or	NULL
increasing	NULL
amounts	NULL
(	NULL
0.2	NULL
,	NULL
2.0	NULL
,	NULL
or	NULL
20	NULL
ug	NULL
)	NULL
of	NULL
genomic	NULL
Z	NULL
(	NULL
gZ	NULL
)	NULL
(	NULL
lanes	NULL
4	NULL
to	NULL
6	NULL
,	NULL
respectively	NULL
)	NULL
or	NULL
gZ	NULL
(	NULL
S186A	NULL
)	NULL
(	NULL
lanes	NULL
8	NULL
to	NULL
10	NULL
,	NULL
respectively	NULL
)	NULL
.	NULL

At	NULL
20	NULL
h	NULL
posttransfection	NULL
,	NULL
cytoplasmic	NULL
RNA	NULL
was	NULL
subjected	NULL
to	NULL
Northern	NULL
blotting	NULL
and	NULL
probed	NULL
with	NULL
a	NULL
*Â°P-labelled	NULL
Fag	NULL
!	NULL

restriction	NULL
fragment	NULL
to	NULL
detect	NULL
the	NULL
BMRF1	NULL
and	NULL
BaRF1i	NULL
mRNAs	NULL
.	NULL

P3J-HR-1	NULL
clone	NULL
16	NULL
cells	NULL
induced	NULL
into	NULL
lytic	NULL
cycle	NULL
transcription	NULL
with	NULL
TPA	NULL
and	NULL
sodium	NULL
butyrate	NULL
(	NULL
cl	NULL
.	NULL

16	NULL
+	NULL
T/B	NULL
)	NULL
(	NULL
lane	NULL
1	NULL
)	NULL
served	NULL
as	NULL
a	NULL
positive	NULL
control	NULL
for	NULL
detection	NULL
of	NULL
lytic	NULL
cycle	NULL
transcripts	NULL
.	NULL

(	NULL
B	NULL
)	NULL
The	NULL
same	NULL
blot	NULL
shown	NULL
in	NULL
panel	NULL
A	NULL
was	NULL
reprobed	NULL
with	NULL
a	NULL
*Â°P-labelled	NULL
TagI-to-Sa/l	NULL
restriction	NULL
fragment	NULL
to	NULL
detect	NULL
the	NULL
BRLF1	NULL
mRNA	NULL
.	NULL

(	NULL
C	NULL
)	NULL
Abundance	NULL
of	NULL
constitutively	NULL
expressed	NULL
cellular	NULL
H1	NULL
RNA	NULL
of	NULL
RNase	NULL
P	NULL
(	NULL
0.35	NULL
kb	NULL
)	NULL
,	NULL
which	NULL
served	NULL
as	NULL
a	NULL
control	NULL
for	NULL
RNA	NULL
loading	NULL
.	NULL

however	NULL
,	NULL
at	NULL
an	NULL
input	NULL
of	NULL
1.0	NULL
ug	NULL
,	NULL
ZEBRA	NULL
appeared	NULL
to	NULL
be	NULL
better	NULL
than	NULL
Z	NULL
(	NULL
S186T	NULL
)	NULL
at	NULL
inducing	NULL
EA-D	NULL
expression	NULL
.	NULL

This	NULL
experiment	NULL
showed	NULL
that	NULL
mutation	NULL
of	NULL
serine	NULL
186	NULL
to	NULL
an	NULL
alanine	NULL
abolished	NULL
the	NULL
capacity	NULL
of	NULL
the	NULL
ZEBRA	NULL
protein	NULL
to	NULL
initiate	NULL
entry	NULL
into	NULL
the	NULL
lytic	NULL
cycle	NULL
of	NULL
EBV	NULL
without	NULL
affecting	NULL
protein	NULL
expression	NULL
or	NULL
impairing	NULL
transcriptional	NULL
activation	NULL
from	NULL
reporter	NULL
plasmids	NULL
in	NULL
the	NULL
same	NULL
cells	NULL
at	NULL
the	NULL
same	NULL
time	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
a	NULL
conservative	NULL
serine-to-threonine	NULL
mutation	NULL
did	NULL
not	NULL
have	NULL
the	NULL
same	NULL
debilitating	NULL
affect	NULL
on	NULL
the	NULL
ability	NULL
to	NULL
disrupt	NULL
EBV	NULL
latency	NULL
.	NULL

DISCUSSION	NULL
The	NULL
major	NULL
biological	NULL
function	NULL
attributed	NULL
to	NULL
ZEBRA	NULL
is	NULL
activation	NULL
of	NULL
the	NULL
EBV	NULL
lytic	NULL
cascade	NULL
.	NULL

It	NULL
induces	NULL
expression	NULL
of	NULL
early	NULL
viral	NULL
genes	NULL
and	NULL
plays	NULL
a	NULL
role	NULL
in	NULL
viral	NULL
replication	NULL
(	NULL
8	NULL
,	NULL
21	NULL
,	NULL
22	NULL
,	NULL
27	NULL
,	NULL
41	NULL
,	NULL
42	NULL
)	NULL
.	NULL

We	NULL
created	NULL
a	NULL
ZEBRA	NULL
mutant	NULL
,	NULL
Z	NULL
(	NULL
S186A	NULL
)	NULL
,	NULL
that	NULL
was	NULL
competent	NULL
in	NULL
assays	NULL
of	NULL
DNA	NULL
binding	NULL
and	NULL
transcriptional	NULL
activation	NULL
but	NULL
was	NULL
not	NULL
sufficient	NULL
to	NULL
drive	NULL
expression	NULL
of	NULL
early	NULL
lytic	NULL
cycle	NULL
genes	NULL
from	NULL
the	NULL
latent	NULL
virus	NULL
.	NULL

Several	NULL
explanations	NULL
could	NULL
account	NULL
for	NULL
the	NULL
phenotype	NULL
of	NULL
the	NULL
Z	NULL
(	NULL
S186A	NULL
)	NULL
mutant	NULL
.	NULL

These	NULL
include	NULL
alterations	NULL
in	NULL
DNA-binding	NULL
specificity	NULL
,	NULL
transcriptional	NULL
activa-	NULL
Vor	NULL
.	NULL

71	NULL
,	NULL
1997	NULL
Z	NULL
(	NULL
S1B6A	NULL
)	NULL
FAILS	NULL
TO	NULL
DISRUPT	NULL
LATENCY	NULL
_	NULL
3059	NULL
A	NULL
REPORTER	NULL
:	NULL
BMRF1p-CAT	NULL
(	NULL
5ug	NULL
)	NULL
[	NULL
1	NULL
ACTIVATOR	NULL
:	NULL
CMV	NULL
gZ	NULL
gZ	NULL
(	NULL
S186A	NULL
)	NULL
gZ	NULL
(	NULL
S186T	NULL
)	NULL
[	NULL
1	NULL
I	NULL
1	NULL
1	NULL
10ug	NULL
0.1ng	NULL
1.0ug	NULL
10ug	NULL
0	NULL
.	NULL

1.0ug	NULL
101g	NULL
O.	NULL
ing	NULL
1.0ug	NULL
CELL	NULL
LINE	NULL
:	NULL
RAJI	NULL
%	NULL
ACETYLATION	NULL
:	NULL
0.2	NULL
0.5	NULL
1	NULL
STIMULATION	NULL
:	NULL
3	NULL
X	NULL
7	NULL
%	NULL
1	NULL
2	NULL
3	NULL
B	NULL
)	NULL
m	NULL
Fa	NULL
f	NULL
in	NULL
e	NULL
3	NULL
&	NULL
Â®	NULL
_	NULL
p	NULL
N	NULL
N	NULL
N	NULL
C	NULL
O	NULL
o	NULL
&	NULL
&	NULL
-	NULL
Markers	NULL
DNA	NULL
(	NULL
ug	NULL
)	NULL
:	NULL
10	NULL
of	NULL
te	NULL
10	NULL
oi	NULL
10	NULL
10	NULL
,	NULL
01	NULL
10	NULL
,	NULL
(	NULL
kD	NULL
)	NULL
Â«	NULL
rp	NULL
EA-D	NULL
-	NULL
a	NULL
=	NULL
50	NULL
ZEBRA	NULL
-	NULL
-32.5	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
7	NULL
8	NULL
9	NULL
10	NULL
SERA	NULL
:	NULL
ANTI-BZLF1	NULL
AND	NULL
ANTI-BMRF1	NULL
tion	NULL
potency	NULL
,	NULL
phosphorylation	NULL
state	NULL
,	NULL
protein-protein	NULL
interac-tions	NULL
,	NULL
and	NULL
capacity	NULL
to	NULL
access	NULL
promoter	NULL
DNA	NULL
sequences	NULL
.	NULL

This	NULL
system	NULL
can	NULL
be	NULL
likened	NULL
to	NULL
the	NULL
studies	NULL
of	NULL
MyoD	NULL
,	NULL
in	NULL
which	NULL
DNA	NULL
binding	NULL
,	NULL
transcriptional	NULL
activation	NULL
,	NULL
and	NULL
initiation	NULL
of	NULL
the	NULL
myogenic	NULL
differentiation	NULL
program	NULL
are	NULL
events	NULL
that	NULL
can	NULL
be	NULL
separated	NULL
by	NULL
introducing	NULL
mutations	NULL
in	NULL
the	NULL
basic	NULL
domain	NULL
of	NULL
the	NULL
protein	NULL
(	NULL
17	NULL
,	NULL
47	NULL
)	NULL
.	NULL

We	NULL
were	NULL
unable	NULL
to	NULL
demonstrate	NULL
a	NULL
difference	NULL
between	NULL
the	NULL
mutant	NULL
and	NULL
wild-type	NULL
ZEBRA	NULL
proteins	NULL
'	NULL
abilities	NULL
to	NULL
recognize	NULL
ZREs	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
and	NULL
3	NULL
)	NULL
.	NULL

However	NULL
,	NULL
Z	NULL
(	NULL
S186A	NULL
)	NULL
may	NULL
have	NULL
an	NULL
increased	NULL
ability	NULL
to	NULL
bind	NULL
to	NULL
an	NULL
AP-1	NULL
octamer	NULL
site	NULL
,	NULL
which	NULL
is	NULL
recognized	NULL
by	NULL
c-Fos	NULL
and	NULL
c-Jun	NULL
but	NULL
not	NULL
by	NULL
wild-type	NULL
ZEBRA	NULL
.	NULL

These	NULL
results	NULL
suggest	NULL
that	NULL
the	NULL
serine-to-alanine	NULL
mutant	NULL
may	NULL
represent	NULL
an	NULL
intermediate	NULL
between	NULL
ZEBRA	NULL
and	NULL
the	NULL
components	NULL
of	NULL
AP-1	NULL
binding	NULL
activity	NULL
,	NULL
c-Fos	NULL
and	NULL
c-Jun	NULL
.	NULL

Our	NULL
DNA-binding	NULL
studies	NULL
focused	NULL
on	NULL
five	NULL
different	NULL
recognition	NULL
sites	NULL
,	NULL
including	NULL
those	NULL
that	NULL
are	NULL
present	NULL
in	NULL
the	NULL
promoters	NULL
for	NULL
the	NULL
ZEBRA	NULL
gene	NULL
itself	NULL
,	NULL
as	NULL
it	NULL
is	NULL
there	NULL
that	NULL
the	NULL
critical	NULL
early	NULL
event	NULL
(	NULL
s	NULL
)	NULL
in	NULL
disruption	NULL
of	NULL
latency	NULL
is	NULL
likely	NULL
to	NULL
occur	NULL
.	NULL

The	NULL
ZEBRA	NULL
protein	NULL
can	NULL
be	NULL
expressed	NULL
from	NULL
the	NULL
BRLF1	NULL
promoter	NULL
,	NULL
which	NULL
contains	NULL
a	NULL
ZIIIA	NULL
site	NULL
and	NULL
a	NULL
ZRE-R	NULL
site	NULL
,	NULL
or	NULL
from	NULL
the	NULL
BZLF1	NULL
promoter	NULL
,	NULL
which	NULL
contains	NULL
two	NULL
ZIIIA	NULL
sites	NULL
,	NULL
one	NULL
ZIIIB	NULL
site	NULL
,	NULL
and	NULL
an	NULL
AP-1	NULL
octamer	NULL
site	NULL
(	NULL
22	NULL
,	NULL
23	NULL
,	NULL
43	NULL
)	NULL
.	NULL

Whereas	NULL
replacement	NULL
of	NULL
the	NULL
entire	NULL
basic	NULL
domain	NULL
of	NULL
ZEBRA	NULL
with	NULL
that	NULL
of	NULL
c-Fos	NULL
abolished	NULL
binding	NULL
to	NULL
synthetic	NULL
oligonucleotides	NULL
containing	NULL
ZIIIB	NULL
and	NULL
ZRE-R	NULL
sites	NULL
and	NULL
reduced	NULL
binding	NULL
to	NULL
ZIIIA	NULL
sites	NULL
in	NULL
vitro	NULL
,	NULL
it	NULL
destroyed	NULL
the	NULL
ability	NULL
to	NULL
disrupt	NULL
EBV	NULL
latency	NULL
;	NULL
binding	NULL
to	NULL
these	NULL
three	NULL
sites	NULL
was	NULL
unchanged	NULL
by	NULL
the	NULL
mutation	NULL
of	NULL
serine	NULL
186	NULL
of	NULL
ZEBRA	NULL
to	NULL
alanine	NULL
(	NULL
30	NULL
)	NULL
.	NULL

Although	NULL
based	NULL
on	NULL
these	NULL
studies	NULL
of	NULL
several	NULL
important	NULL
ZREs	NULL
we	NULL
believe	NULL
that	NULL
DNA-binding	NULL
effects	NULL
are	NULL
unlikely	NULL
to	NULL
explain	NULL
the	NULL
failure	NULL
of	NULL
Z	NULL
(	NULL
S186A	NULL
)	NULL
to	NULL
disrupt	NULL
latency	NULL
,	NULL
it	NULL
remains	NULL
possible	NULL
that	NULL
this	NULL
mutation	NULL
affects	NULL
binding	NULL
to	NULL
other	NULL
,	NULL
as	NULL
we	NULL
~	NULL
@	NULL
5	NULL
81	NULL
25X	NULL
-	NULL
405	NULL
%	NULL
5	NULL
0.3	NULL
25X	NULL
-	NULL
2	NULL
%	NULL
2	NULL
4	NULL
10	NULL
%	NULL
X	NULL
20	NULL
%	NULL
4	NULL
5	NULL
6	NULL
7	NULL
8	NULL
9	NULL
FIG	NULL
.	NULL

7	NULL
.	NULL

Comparison	NULL
of	NULL
the	NULL
abilities	NULL
of	NULL
ZEBRA	NULL
,	NULL
Z	NULL
(	NULL
S186A	NULL
)	NULL
,	NULL
and	NULL
Z	NULL
(	NULL
S186T	NULL
)	NULL
to	NULL
activate	NULL
the	NULL
BMRF1	NULL
promoter	NULL
from	NULL
a	NULL
reporter	NULL
construct	NULL
and	NULL
in	NULL
the	NULL
context	NULL
of	NULL
the	NULL
intact	NULL
viral	NULL
genome	NULL
in	NULL
Raji	NULL
cells	NULL
.	NULL

Cells	NULL
were	NULL
transfected	NULL
with	NULL
BMRF1p-CAT	NULL
(	NULL
5	NULL
ug	NULL
)	NULL
and	NULL
increasing	NULL
amounts	NULL
(	NULL
0.1	NULL
,	NULL
1.0	NULL
,	NULL
or	NULL
10	NULL
ug	NULL
)	NULL
of	NULL
genomic	NULL
ZEBRA	NULL
,	NULL
Z	NULL
(	NULL
S186A	NULL
)	NULL
,	NULL
or	NULL
Z	NULL
(	NULL
S186T	NULL
)	NULL
.	NULL

After	NULL
3	NULL
days	NULL
,	NULL
both	NULL
CAT	NULL
activity	NULL
and	NULL
lytic	NULL
protein	NULL
expression	NULL
were	NULL
measured	NULL
in	NULL
the	NULL
same	NULL
cell	NULL
extracts	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Representative	NULL
data	NULL
showing	NULL
CAT	NULL
activity	NULL
in	NULL
cell	NULL
extracts	NULL
from	NULL
transfected	NULL
Raji	NULL
cells	NULL
expressing	NULL
the	NULL
CMV	NULL
vector	NULL
alone	NULL
(	NULL
lane	NULL
1	NULL
)	NULL
,	NULL
ZEBRA	NULL
(	NULL
lanes	NULL
2	NULL
to	NULL
4	NULL
)	NULL
,	NULL
Z	NULL
(	NULL
S186A	NULL
)	NULL
(	NULL
lanes	NULL
5	NULL
to	NULL
7	NULL
)	NULL
,	NULL
or	NULL
Z	NULL
(	NULL
S186T	NULL
)	NULL
(	NULL
lanes	NULL
8	NULL
and	NULL
9	NULL
)	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
BMRF1ip-CAT	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Western	NULL
blotting	NULL
of	NULL
whole-cell	NULL
extracts	NULL
with	NULL
antibodies	NULL
that	NULL
specifically	NULL
recognize	NULL
the	NULL
ZEBRA	NULL
and	NULL
BMRF1	NULL
(	NULL
EA-D	NULL
)	NULL
proteins	NULL
.	NULL

Raji	NULL
cells	NULL
chemically	NULL
induced	NULL
with	NULL
TPA	NULL
and	NULL
sodium	NULL
butyrate	NULL
(	NULL
T/B	NULL
)	NULL
(	NULL
lane	NULL
1	NULL
)	NULL
served	NULL
as	NULL
a	NULL
positive	NULL
control	NULL
for	NULL
expression	NULL
of	NULL
lytic	NULL
cycle	NULL
polypeptides	NULL
.	NULL

yet	NULL
unidentified	NULL
,	NULL
ZREs	NULL
that	NULL
are	NULL
important	NULL
for	NULL
the	NULL
switch	NULL
to	NULL
the	NULL
lytic	NULL
phase	NULL
of	NULL
the	NULL
viral	NULL
life	NULL
cycle	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
changes	NULL
in	NULL
DNA-binding	NULL
affinity	NULL
rather	NULL
than	NULL
site	NULL
selection	NULL
could	NULL
affect	NULL
the	NULL
ability	NULL
to	NULL
disrupt	NULL
latency	NULL
.	NULL

The	NULL
DNA-binding	NULL
affinities	NULL
of	NULL
ZEBRA	NULL
and	NULL
Z	NULL
(	NULL
S186A	NULL
)	NULL
for	NULL
an	NULL
oligonucleotide	NULL
containing	NULL
a	NULL
ZRE2	NULL
site	NULL
appear	NULL
to	NULL
be	NULL
identical	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
;	NULL
however	NULL
,	NULL
the	NULL
mutant	NULL
may	NULL
have	NULL
altered	NULL
affinities	NULL
on	NULL
other	NULL
sites	NULL
that	NULL
are	NULL
crucial	NULL
for	NULL
the	NULL
disruption	NULL
of	NULL
latency	NULL
.	NULL

An	NULL
unexpected	NULL
finding	NULL
was	NULL
that	NULL
the	NULL
S186A	NULL
mutant	NULL
retained	NULL
the	NULL
ability	NULL
to	NULL
bind	NULL
ZREs	NULL
.	NULL

The	NULL
mutation	NULL
altered	NULL
the	NULL
basic	NULL
domain	NULL
so	NULL
that	NULL
all	NULL
five	NULL
of	NULL
the	NULL
amino	NULL
acids	NULL
of	NULL
c-Fos	NULL
and	NULL
c-Jun	NULL
that	NULL
contacted	NULL
DNA	NULL
in	NULL
the	NULL
X-ray	NULL
crystal	NULL
structure	NULL
were	NULL
now	NULL
identical	NULL
in	NULL
ZEBRA	NULL
.	NULL

c-Fos	NULL
and	NULL
c-Jun	NULL
are	NULL
unable	NULL
to	NULL
bind	NULL
ZREs	NULL
;	NULL
therefore	NULL
,	NULL
the	NULL
capacity	NULL
of	NULL
Z	NULL
(	NULL
S186A	NULL
)	NULL
to	NULL
recognize	NULL
ZREs	NULL
must	NULL
involve	NULL
residues	NULL
or	NULL
a	NULL
tertiary	NULL
structure	NULL
other	NULL
than	NULL
that	NULL
found	NULL
to	NULL
be	NULL
important	NULL
for	NULL
binding	NULL
of	NULL
c-Fos	NULL
and	NULL
c-Jun	NULL
to	NULL
an	NULL
AP-1	NULL
site	NULL
.	NULL

This	NULL
hypothesis	NULL
is	NULL
also	NULL
supported	NULL
by	NULL
the	NULL
finding	NULL
that	NULL
phosphorylation	NULL
or	NULL
mutation	NULL
of	NULL
serine	NULL
173	NULL
in	NULL
ZEBRA	NULL
,	NULL
a	NULL
residue	NULL
outside	NULL
of	NULL
the	NULL
canonical	NULL
basic	NULL
region	NULL
,	NULL
abrogated	NULL
DNA	NULL
binding	NULL
(	NULL
29	NULL
)	NULL
.	NULL

This	NULL
suggests	NULL
that	NULL
the	NULL
ZEBRA	NULL
protein	NULL
recognizes	NULL
its	NULL
specific	NULL
sites	NULL
in	NULL
DNA	NULL
in	NULL
a	NULL
manner	NULL
that	NULL
is	NULL
distinct	NULL
from	NULL
that	NULL
used	NULL
by	NULL
two	NULL
other	NULL
members	NULL
of	NULL
the	NULL
bZIP	NULL
family	NULL
of	NULL
transcription	NULL
factors	NULL
,	NULL
c-Fos	NULL
and	NULL
c-Jun	NULL
.	NULL

A	NULL
prevalent	NULL
model	NULL
of	NULL
ZEBRA	NULL
's	NULL
action	NULL
held	NULL
that	NULL
the	NULL
capacity	NULL
to	NULL
disrupt	NULL
latency	NULL
was	NULL
tightly	NULL
linked	NULL
to	NULL
its	NULL
transcriptional	NULL
activation	NULL
potency	NULL
(	NULL
4	NULL
)	NULL
.	NULL

However	NULL
,	NULL
Z	NULL
(	NULL
S186A	NULL
)	NULL
was	NULL
not	NULL
impaired	NULL
in	NULL
transcriptional	NULL
activation	NULL
of	NULL
reporters	NULL
containing	NULL
promoters	NULL
of	NULL
several	NULL
EBV	NULL
early	NULL
lytic	NULL
cycle	NULL
genes	NULL
.	NULL

In	NULL
fact	NULL
,	NULL
Z	NULL
(	NULL
S186A	NULL
)	NULL
had	NULL
an	NULL
enhanced	NULL
ability	NULL
to	NULL
activate	NULL
BMRF1-CAT	NULL
in	NULL
comparison	NULL
to	NULL
the	NULL
wild	NULL
type	NULL
but	NULL
could	NULL
not	NULL
promote	NULL
expression	NULL
of	NULL
viral	NULL
BMRF1	NULL
transcripts	NULL
or	NULL
their	NULL
protein	NULL
product	NULL
,	NULL
EA-D	NULL
,	NULL
from	NULL
the	NULL
viral	NULL
genome	NULL
.	NULL

The	NULL
Z	NULL
(	NULL
S186A	NULL
)	NULL
mutant	NULL
could	NULL
also	NULL
activate	NULL
the	NULL
promoters	NULL
of	NULL
the	NULL
BRLF1	NULL
and	NULL
BZLF1	NULL
genes	NULL
and	NULL
synergize	NULL
with	NULL
the	NULL
EBV	NULL
Rta	NULL
transcription	NULL
factor	NULL
in	NULL
activating	NULL
the	NULL
BHLF1-BHRF1	NULL
divergent	NULL
promoter	NULL
when	NULL
linked	NULL
to	NULL
CAT	NULL
as	NULL
well	NULL
as	NULL
wild-type	NULL
ZEBRA	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Our	NULL
finding	NULL
that	NULL
Z	NULL
(	NULL
S186AÂ¥	NULL
)	NULL
bound	NULL
DNA	NULL
and	NULL
activated	NULL
transcription	NULL
makes	NULL
it	NULL
unlikely	NULL
that	NULL
folding	NULL
3060	NULL
FRANCIS	NULL
ET	NULL
AL	NULL
.	NULL

of	NULL
the	NULL
mutant	NULL
protein	NULL
is	NULL
significantly	NULL
altered	NULL
from	NULL
that	NULL
of	NULL
the	NULL
wild	NULL
type	NULL
.	NULL

A	NULL
formal	NULL
possibility	NULL
that	NULL
has	NULL
not	NULL
been	NULL
excluded	NULL
is	NULL
that	NULL
none	NULL
of	NULL
the	NULL
promoters	NULL
used	NULL
in	NULL
our	NULL
reporter	NULL
assays	NULL
contains	NULL
critical	NULL
upstream	NULL
or	NULL
downstream	NULL
information	NULL
that	NULL
discriminates	NULL
the	NULL
functions	NULL
of	NULL
wild-type	NULL
ZEBRA	NULL
and	NULL
the	NULL
Z	NULL
(	NULL
S186A	NULL
)	NULL
mutant	NULL
.	NULL

ZEBRA	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
be	NULL
phosphorylated	NULL
on	NULL
serine	NULL
residues	NULL
in	NULL
vivo	NULL
;	NULL
however	NULL
,	NULL
the	NULL
role	NULL
of	NULL
phosphorylation	NULL
in	NULL
ZEBRA	NULL
's	NULL
biological	NULL
activity	NULL
has	NULL
not	NULL
been	NULL
established	NULL
(	NULL
14	NULL
)	NULL
.	NULL

It	NULL
is	NULL
possible	NULL
that	NULL
phosphorylation	NULL
of	NULL
serine	NULL
is	NULL
required	NULL
for	NULL
ZEBRA-mediated	NULL
disruption	NULL
of	NULL
latency	NULL
.	NULL

Interestingly	NULL
,	NULL
the	NULL
serine	NULL
at	NULL
position	NULL
186	NULL
of	NULL
the	NULL
ZEBRA	NULL
protein	NULL
fits	NULL
the	NULL
consensus	NULL
for	NULL
a	NULL
potential	NULL
site	NULL
for	NULL
phosphorylation	NULL
by	NULL
protein	NULL
kinase	NULL
C	NULL
(	NULL
PKC	NULL
)	NULL
(	NULL
48	NULL
)	NULL
.	NULL

This	NULL
observation	NULL
is	NULL
intriguing	NULL
in	NULL
light	NULL
of	NULL
the	NULL
fact	NULL
that	NULL
the	NULL
PKC	NULL
signal	NULL
transduction	NULL
pathway	NULL
has	NULL
been	NULL
implicated	NULL
in	NULL
induction	NULL
of	NULL
EBV	NULL
lytic	NULL
cycle	NULL
transcription	NULL
following	NULL
cross-linking	NULL
of	NULL
surface	NULL
immunoglobulins	NULL
in	NULL
Akata	NULL
cells	NULL
.	NULL

PKC	NULL
inhib-itors	NULL
block	NULL
the	NULL
anti-immunoglobulin	NULL
G	NULL
inducibility	NULL
of	NULL
the	NULL
BZLF1	NULL
promoter	NULL
in	NULL
CAT	NULL
assays	NULL
and	NULL
prevent	NULL
the	NULL
appearance	NULL
of	NULL
lytic	NULL
cycle	NULL
transcripts	NULL
from	NULL
the	NULL
virus	NULL
(	NULL
15	NULL
,	NULL
34	NULL
)	NULL
.	NULL

Preliminary	NULL
results	NULL
reveal	NULL
that	NULL
bacterially	NULL
expressed	NULL
ZEBRA	NULL
protein	NULL
can	NULL
indeed	NULL
serve	NULL
as	NULL
a	NULL
substrate	NULL
for	NULL
PKC	NULL
in	NULL
vitro	NULL
(	NULL
24a	NULL
)	NULL
.	NULL

Notably	NULL
,	NULL
the	NULL
mutant	NULL
Z	NULL
(	NULL
S186T	NULL
)	NULL
,	NULL
in	NULL
which	NULL
serine	NULL
186	NULL
is	NULL
replaced	NULL
by	NULL
threo-nine	NULL
,	NULL
retains	NULL
a	NULL
consensus	NULL
PKC	NULL
site	NULL
and	NULL
also	NULL
retains	NULL
the	NULL
ability	NULL
to	NULL
disrupt	NULL
latency	NULL
(	NULL
Fig	NULL
.	NULL

7B	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
presence	NULL
of	NULL
either	NULL
a	NULL
serine	NULL
or	NULL
a	NULL
threonine	NULL
at	NULL
position	NULL
186	NULL
enables	NULL
ZEBRA	NULL
to	NULL
disrupt	NULL
latency	NULL
,	NULL
a	NULL
feature	NULL
which	NULL
can	NULL
not	NULL
be	NULL
conferred	NULL
by	NULL
alanine	NULL
at	NULL
the	NULL
same	NULL
position	NULL
.	NULL

Phosphorylation	NULL
of	NULL
serine	NULL
or	NULL
threonine	NULL
at	NULL
position	NULL
186	NULL
could	NULL
change	NULL
the	NULL
DNA-binding	NULL
affinity	NULL
or	NULL
specificity	NULL
of	NULL
the	NULL
ZEBRA	NULL
protein	NULL
,	NULL
or	NULL
it	NULL
could	NULL
be	NULL
required	NULL
for	NULL
interaction	NULL
with	NULL
another	NULL
protein	NULL
.	NULL

Although	NULL
our	NULL
data	NULL
suggest	NULL
that	NULL
an	NULL
intact	NULL
PKC	NULL
phosphorylation	NULL
site	NULL
at	NULL
amino	NULL
acid	NULL
186	NULL
of	NULL
the	NULL
ZEBRA	NULL
protein	NULL
correlates	NULL
with	NULL
the	NULL
ability	NULL
of	NULL
the	NULL
protein	NULL
to	NULL
disrupt	NULL
EBV	NULL
latency	NULL
,	NULL
it	NULL
is	NULL
not	NULL
yet	NULL
known	NULL
if	NULL
serine	NULL
186	NULL
is	NULL
a	NULL
target	NULL
for	NULL
phosphorylation	NULL
in	NULL
vivo	NULL
.	NULL

There	NULL
is	NULL
much	NULL
evidence	NULL
that	NULL
ZEBRA	NULL
directly	NULL
interacts	NULL
with	NULL
other	NULL
proteins	NULL
(	NULL
26	NULL
,	NULL
28	NULL
,	NULL
35	NULL
,	NULL
44	NULL
,	NULL
49	NULL
,	NULL
50	NULL
)	NULL
.	NULL

The	NULL
mutation	NULL
of	NULL
serine	NULL
186	NULL
to	NULL
alanine	NULL
in	NULL
the	NULL
ZEBRA	NULL
protein	NULL
could	NULL
destroy	NULL
a	NULL
contact	NULL
that	NULL
is	NULL
required	NULL
for	NULL
disruption	NULL
of	NULL
latency	NULL
,	NULL
thereby	NULL
resulting	NULL
in	NULL
the	NULL
observed	NULL
phenotype	NULL
.	NULL

There	NULL
are	NULL
several	NULL
examples	NULL
of	NULL
protein-protein	NULL
contacts	NULL
that	NULL
are	NULL
made	NULL
through	NULL
the	NULL
basic	NULL
DNA-binding	NULL
region	NULL
of	NULL
proteins	NULL
.	NULL

The	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
transactivator	NULL
Tax	NULL
is	NULL
capable	NULL
of	NULL
binding	NULL
to	NULL
the	NULL
basic	NULL
region	NULL
of	NULL
peptides	NULL
containing	NULL
the	NULL
GCN4	NULL
bZIP	NULL
region	NULL
.	NULL

This	NULL
interaction	NULL
stabilizes	NULL
the	NULL
GCN4	NULL
homodimer	NULL
and	NULL
increases	NULL
the	NULL
DNA-binding	NULL
affinity	NULL
of	NULL
the	NULL
protein	NULL
(	NULL
2	NULL
)	NULL
.	NULL

Similarly	NULL
,	NULL
the	NULL
cellular	NULL
high-mo-bility-group	NULL
protein	NULL
HMG	NULL
I	NULL
(	NULL
Y	NULL
)	NULL
can	NULL
bind	NULL
to	NULL
the	NULL
bZIP	NULL
region	NULL
of	NULL
activating	NULL
transcription	NULL
factor	NULL
2	NULL
.	NULL

This	NULL
interaction	NULL
stimulates	NULL
the	NULL
binding	NULL
of	NULL
activating	NULL
transcription	NULL
factor	NULL
2	NULL
to	NULL
a	NULL
site	NULL
in	NULL
the	NULL
beta	NULL
interferon	NULL
promoter	NULL
by	NULL
promoting	NULL
dimerization	NULL
of	NULL
this	NULL
transcription	NULL
factor	NULL
(	NULL
18	NULL
)	NULL
.	NULL

A	NULL
similar	NULL
mechanism	NULL
involving	NULL
protein-protein	NULL
contacts	NULL
in	NULL
the	NULL
basic	NULL
domain	NULL
of	NULL
ZEBRA	NULL
may	NULL
affect	NULL
its	NULL
capacity	NULL
to	NULL
bind	NULL
or	NULL
activate	NULL
transcription	NULL
from	NULL
the	NULL
latent	NULL
viral	NULL
DNA	NULL
.	NULL

Our	NULL
results	NULL
revealed	NULL
a	NULL
dramatic	NULL
difference	NULL
in	NULL
the	NULL
level	NULL
of	NULL
transcription	NULL
scored	NULL
from	NULL
a	NULL
viral	NULL
promoter	NULL
in	NULL
the	NULL
context	NULL
of	NULL
a	NULL
transfected	NULL
reporter	NULL
construct	NULL
and	NULL
that	NULL
observed	NULL
from	NULL
the	NULL
same	NULL
promoter	NULL
as	NULL
part	NULL
of	NULL
the	NULL
viral	NULL
genome	NULL
in	NULL
response	NULL
to	NULL
Z	NULL
(	NULL
S186A	NULL
)	NULL
.	NULL

Therefore	NULL
,	NULL
there	NULL
may	NULL
be	NULL
a	NULL
property	NULL
of	NULL
the	NULL
promoter	NULL
DNA	NULL
itself	NULL
that	NULL
is	NULL
responsible	NULL
for	NULL
the	NULL
observed	NULL
differences	NULL
in	NULL
the	NULL
activities	NULL
of	NULL
ZEBRA	NULL
and	NULL
the	NULL
S186A	NULL
mutant	NULL
.	NULL

ZEBRA	NULL
's	NULL
initial	NULL
role	NULL
in	NULL
disruption	NULL
of	NULL
latency	NULL
may	NULL
be	NULL
to	NULL
alter	NULL
the	NULL
state	NULL
of	NULL
the	NULL
viral	NULL
DNA	NULL
in	NULL
order	NULL
to	NULL
allow	NULL
initiation	NULL
of	NULL
lytic	NULL
cycle	NULL
gene	NULL
transcription	NULL
.	NULL

Transfected	NULL
plasmid	NULL
DNA	NULL
may	NULL
not	NULL
require	NULL
such	NULL
a	NULL
reorganization	NULL
event	NULL
.	NULL

The	NULL
phenotype	NULL
of	NULL
the	NULL
Z	NULL
(	NULL
S186A	NULL
)	NULL
mutation	NULL
could	NULL
be	NULL
explained	NULL
if	NULL
the	NULL
amino	NULL
acid	NULL
change	NULL
impaired	NULL
J.	NULL
ViRoL	NULL
.	NULL

ZEBRA	NULL
's	NULL
ability	NULL
to	NULL
facilitate	NULL
chromatin	NULL
reorganization	NULL
of	NULL
the	NULL
latent	NULL
viral	NULL
genome	NULL
while	NULL
leaving	NULL
unchanged	NULL
its	NULL
ability	NULL
to	NULL
carry	NULL
out	NULL
the	NULL
downstream	NULL
events	NULL
of	NULL
DNA	NULL
binding	NULL
and	NULL
transcriptional	NULL
activation	NULL
.	NULL

A	NULL
ZEBRA-mediated	NULL
nucleosomal	NULL
rearrangement	NULL
of	NULL
viral	NULL
promoter	NULL
DNA	NULL
could	NULL
involve	NULL
phosphorylation	NULL
on	NULL
serine	NULL
residues	NULL
and/or	NULL
interactions	NULL
with	NULL
other	NULL
proteins	NULL
through	NULL
its	NULL
basic	NULL
region	NULL
.	NULL

Further	NULL
study	NULL
is	NULL
required	NULL
to	NULL
elucidate	NULL
which	NULL
of	NULL
these	NULL
properties	NULL
may	NULL
be	NULL
involved	NULL
in	NULL
induction	NULL
of	NULL
the	NULL
EBV	NULL
lytic	NULL
cycle	NULL
by	NULL
ZEBRA	NULL
.	NULL

Nonetheless	NULL
,	NULL
the	NULL
serine-to-alanine	NULL
mutation	NULL
in	NULL
the	NULL
DNA-binding	NULL
domain	NULL
of	NULL
the	NULL
ZEBRA	NULL
protein	NULL
distinguishes	NULL
its	NULL
functions	NULL
in	NULL
transcriptional	NULL
activation	NULL
and	NULL
disruption	NULL
of	NULL
EBV	NULL
latency	NULL
.	NULL

ACKNOWLEDGMENTS	NULL
We	NULL
thank	NULL
R.	NULL
Baumann	NULL
,	NULL
L.	NULL
Heston	NULL
,	NULL
J.	NULL
L.	NULL
Kolman	NULL
,	NULL
and	NULL
Y.	NULL
Yuan	NULL
for	NULL
gifts	NULL
of	NULL
recombinant	NULL
plasmids	NULL
.	NULL

We	NULL
also	NULL
appreciate	NULL
the	NULL
generous	NULL
efforts	NULL
of	NULL
M.	NULL
Biggin	NULL
,	NULL
M.	NULL
Carey	NULL
,	NULL
D.	NULL
Crothers	NULL
,	NULL
D.	NULL
DiMaio	NULL
,	NULL
J.	NULL
L.	NULL
Kolman	NULL
,	NULL
S.	NULL
L.	NULL
McKnight	NULL
,	NULL
T.	NULL
Serio	NULL
,	NULL
and	NULL
N.	NULL
Taylor	NULL
in	NULL
critically	NULL
reading	NULL
the	NULL
manuscript	NULL
and	NULL
offering	NULL
helpful	NULL
advice	NULL
.	NULL

This	NULL
work	NULL
was	NULL
supported	NULL
by	NULL
National	NULL
Institutes	NULL
of	NULL
Health	NULL
grant	NULL
CA12055	NULL
.	NULL

A.L.F	NULL
.	NULL

received	NULL
financial	NULL
support	NULL
as	NULL
part	NULL
of	NULL
National	NULL
Research	NULL
Service	NULL
Award-Public	NULL
Health	NULL
Service	NULL
Fellowship	NULL
5T32CM	NULL
07223-18	NULL
.	NULL

REFERENCES	NULL
1	NULL
.	NULL

Angeloni	NULL
,	NULL
A.	NULL
,	NULL
L.	NULL
Heston	NULL
,	NULL
and	NULL
G.	NULL
Miller	NULL
.	NULL

Unpublished	NULL
data	NULL
.	NULL

1a.Baer	NULL
,	NULL
R.	NULL
,	NULL
A.	NULL
T.	NULL
Bankier	NULL
,	NULL
M.	NULL
D.	NULL
Biggin	NULL
,	NULL
P.	NULL
L.	NULL
Deininger	NULL
,	NULL
P.	NULL
J.	NULL
Farrell	NULL
,	NULL
T.	NULL
J.	NULL
Gibson	NULL
,	NULL
G.	NULL
Hatful	NULL
,	NULL
G.	NULL
S.	NULL
Hudson	NULL
,	NULL
S.	NULL
C.	NULL
Satchwell	NULL
,	NULL
C.	NULL
Seguin	NULL
,	NULL
P.	NULL
S.	NULL
Tuffenell	NULL
,	NULL
and	NULL
B.	NULL
Barrell	NULL
.	NULL

1984	NULL
.	NULL

DNA	NULL
sequence	NULL
and	NULL
expression	NULL
of	NULL
the	NULL
B95-8	NULL
Epstein-Barr	NULL
virus	NULL
genome	NULL
.	NULL

Nature	NULL
310:207-211	NULL
.	NULL

2	NULL
.	NULL

Baranger	NULL
,	NULL
A.	NULL
M.	NULL
,	NULL
C.	NULL
R.	NULL
Palmer	NULL
,	NULL
M.	NULL
K.	NULL
Hamm	NULL
,	NULL
H.	NULL
A.	NULL
Giebler	NULL
,	NULL
A.	NULL
Brauweiler	NULL
,	NULL
J.	NULL
K.	NULL
Nyborg	NULL
,	NULL
and	NULL
A.	NULL
Schepartz	NULL
.	NULL

1995	NULL
.	NULL

Mechanism	NULL
of	NULL
DNA-binding	NULL
enhancement	NULL
by	NULL
the	NULL
human	NULL
T-cell	NULL
leukaemia	NULL
virus	NULL
transactivator	NULL
Tax	NULL
.	NULL

Nature	NULL
376	NULL
:	NULL
606-608	NULL
.	NULL

3	NULL
.	NULL

Bartkiewicz	NULL
,	NULL
M.	NULL
,	NULL
H.	NULL
Gold	NULL
,	NULL
and	NULL
S.	NULL
Altman	NULL
.	NULL

1989	NULL
.	NULL

Identification	NULL
and	NULL
characterization	NULL
of	NULL
an	NULL
RNA	NULL
molecule	NULL
that	NULL
copurifies	NULL
with	NULL
RNase	NULL
P	NULL
activity	NULL
from	NULL
HeLa	NULL
cells	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

3:488-499	NULL
.	NULL

4	NULL
.	NULL

Baumann	NULL
,	NULL
R.	NULL
,	NULL
E.	NULL
Grogan	NULL
,	NULL
M.	NULL
Ptashne	NULL
,	NULL
and	NULL
G.	NULL
Miller	NULL
.	NULL

1993	NULL
.	NULL

Changing	NULL
Epstein-Barr	NULL
viral	NULL
ZEBRA	NULL
protein	NULL
into	NULL
a	NULL
more	NULL
powerful	NULL
activator	NULL
enhances	NULL
its	NULL
capacity	NULL
to	NULL
disrupt	NULL
latency	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
90:4436-4440	NULL
.	NULL

4a.Carey	NULL
,	NULL
M.	NULL
Personal	NULL
communication	NULL
.	NULL

5	NULL
.	NULL

Carey	NULL
,	NULL
M.	NULL
,	NULL
J.	NULL
Kolman	NULL
,	NULL
D.	NULL
A.	NULL
Katz	NULL
,	NULL
L.	NULL
Gradoville	NULL
,	NULL
L.	NULL
Barberis	NULL
,	NULL
and	NULL
G.	NULL
Miller	NULL
.	NULL

1992	NULL
.	NULL

Transcriptional	NULL
synergy	NULL
by	NULL
the	NULL
Epstein-Barr	NULL
virus	NULL
transactivator	NULL
ZEBRA	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

66:4803-4813	NULL
.	NULL

6	NULL
.	NULL

Chang	NULL
,	NULL
Y.-N.	NULL
,	NULL
D.L.-Y	NULL
.	NULL

Dong	NULL
,	NULL
G.	NULL
S.	NULL
Hayward	NULL
,	NULL
and	NULL
S.	NULL
D.	NULL
Hayward	NULL
.	NULL

1990	NULL
.	NULL

The	NULL
Epstein-Barr	NULL
virus	NULL
Zta	NULL
transactivator	NULL
:	NULL
a	NULL
member	NULL
of	NULL
the	NULL
bZIP	NULL
family	NULL
with	NULL
unique	NULL
DNA-binding	NULL
specificity	NULL
and	NULL
a	NULL
dimerization	NULL
domain	NULL
that	NULL
lacks	NULL
the	NULL
characteristic	NULL
heptad	NULL
leucine	NULL
zipper	NULL
motif	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

64:3358-3369	NULL
.	NULL

7	NULL
.	NULL

Chen	NULL
,	NULL
L.	NULL
W.	NULL
,	NULL
L.	NULL
S.	NULL
Lin	NULL
,	NULL
Y.	NULL
S.	NULL
Chang	NULL
,	NULL
and	NULL
S.	NULL
T.	NULL
Liu	NULL
.	NULL

1995	NULL
.	NULL

Functional	NULL
analysis	NULL
of	NULL
EA-D	NULL
of	NULL
Epstein-Barr	NULL
virus	NULL
.	NULL

Virology	NULL
211:593-597	NULL
.	NULL

8	NULL
.	NULL

Chevallier-Greco	NULL
,	NULL
A.	NULL
,	NULL
E.	NULL
Manet	NULL
,	NULL
P.	NULL
Chavre	NULL
,	NULL
C.	NULL
Mosnier	NULL
,	NULL
J.	NULL
Daillie	NULL
,	NULL
and	NULL
A	NULL
.	NULL

Sergeant	NULL
.	NULL

1986	NULL
.	NULL

Both	NULL
Epstein-Barr	NULL
virus	NULL
(	NULL
EBV	NULL
)	NULL
encoded	NULL
trans-acting	NULL
factors	NULL
,	NULL
EB1	NULL
and	NULL
EB2	NULL
,	NULL
are	NULL
required	NULL
to	NULL
activate	NULL
transcription	NULL
from	NULL
an	NULL
EBV	NULL
carly	NULL
promoter	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

5:3241-3249	NULL
.	NULL

9	NULL
.	NULL

Chi	NULL
,	NULL
T.	NULL
,	NULL
and	NULL
M.	NULL
Carey	NULL
.	NULL

1993	NULL
.	NULL

The	NULL
ZEBRA	NULL
activation	NULL
domain	NULL
:	NULL
modular	NULL
organization	NULL
and	NULL
mechanism	NULL
of	NULL
action	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

13:7045-7055	NULL
.	NULL

10	NULL
.	NULL

Chi	NULL
,	NULL
T.	NULL
,	NULL
P.	NULL
Lieberman	NULL
,	NULL
K.	NULL
Ellwood	NULL
,	NULL
and	NULL
M.	NULL
Carey	NULL
.	NULL

1995	NULL
.	NULL

A	NULL
general	NULL
mechanism	NULL
for	NULL
transcriptional	NULL
activation	NULL
by	NULL
eukaryotic	NULL
activators	NULL
.	NULL

Nature	NULL
377:254-257	NULL
.	NULL

11	NULL
.	NULL

Cho	NULL
,	NULL
M.-S.	NULL
,	NULL
G.	NULL
Milman	NULL
,	NULL
and	NULL
S.	NULL
D.	NULL
Hayward	NULL
.	NULL

1985	NULL
.	NULL

A	NULL
second	NULL
Epstein-Barr	NULL
virus	NULL
carly	NULL
antigen	NULL
gene	NULL
in	NULL
BamHI	NULL
fragment	NULL
M	NULL
encodes	NULL
a	NULL
48-	NULL
to	NULL
50-kilodal-ton	NULL
nuclear	NULL
protein	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

56:860-866	NULL
.	NULL

12	NULL
.	NULL

Countryman	NULL
,	NULL
J.	NULL
,	NULL
H.	NULL
Jenson	NULL
,	NULL
R.	NULL
Seibl	NULL
,	NULL
H.	NULL
Wolf	NULL
,	NULL
and	NULL
G.	NULL
Miller	NULL
.	NULL

1987	NULL
.	NULL

Polymorphic	NULL
proteins	NULL
encoded	NULL
within	NULL
BZLF1	NULL
of	NULL
defective	NULL
and	NULL
standard	NULL
Epstein-Barr	NULL
viruses	NULL
disrupt	NULL
latency	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

61:3672-3679	NULL
.	NULL

13	NULL
.	NULL

Countryman	NULL
,	NULL
J.	NULL
K.	NULL
,	NULL
L.	NULL
Heston	NULL
,	NULL
L.	NULL
Gradoville	NULL
,	NULL
H.	NULL
Himmelfarb	NULL
,	NULL
S.	NULL
Serdy	NULL
,	NULL
and	NULL
G.	NULL
Miller	NULL
,	NULL
1994	NULL
.	NULL

Activation	NULL
of	NULL
the	NULL
Epstein-Barr	NULL
virus	NULL
BMRF1	NULL
and	NULL
BZLF1	NULL
promoters	NULL
by	NULL
ZEBRA	NULL
in	NULL
Saccharomyces	NULL
cerevisiae	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

68:7628-7633	NULL
.	NULL

14	NULL
.	NULL

Daibata	NULL
,	NULL
M.	NULL
,	NULL
R.	NULL
E.	NULL
Humphreys	NULL
,	NULL
and	NULL
T.	NULL
Sairenji	NULL
.	NULL

1992	NULL
.	NULL

Phosphorylation	NULL
of	NULL
the	NULL
Epstein-Barr	NULL
virus	NULL
BZLF1	NULL
immediate-early	NULL
gene	NULL
product	NULL
ZEBRA	NULL
.	NULL

Virology	NULL
188:916-920	NULL
.	NULL

15	NULL
.	NULL

Daibata	NULL
,	NULL
M.	NULL
,	NULL
S.	NULL
H.	NULL
Speck	NULL
,	NULL
C.	NULL
Mulder	NULL
,	NULL
and	NULL
T.	NULL
Sairenji	NULL
.	NULL

1994	NULL
.	NULL

Regulation	NULL
of	NULL
the	NULL
BZLF1	NULL
promoter	NULL
of	NULL
Epstein-Barr	NULL
virus	NULL
by	NULL
second	NULL
messengers	NULL
in	NULL
anti-immu-noglobulin-treated	NULL
B	NULL
cells	NULL
.	NULL

Virology	NULL
198:446-454	NULL
.	NULL

16	NULL
.	NULL

Davis	NULL
,	NULL
M.	NULL
G.	NULL
,	NULL
and	NULL
E.	NULL
S.	NULL
Huang	NULL
.	NULL

1988	NULL
.	NULL

Transfer	NULL
and	NULL
expression	NULL
of	NULL
plasmids	NULL
Vor	NULL
.	NULL

71	NULL
,	NULL
1997	NULL
17	NULL
.	NULL

18	NULL
.	NULL

19	NULL
.	NULL

20	NULL
.	NULL

21	NULL
.	NULL

22	NULL
.	NULL

23	NULL
.	NULL

24.	NULL
containing	NULL
human	NULL
cytomegalovirus	NULL
immediate-early	NULL
gene	NULL
1	NULL
promoter-enhancer	NULL
sequences	NULL
in	NULL
eukaryotic	NULL
and	NULL
prokaryotic	NULL
cells	NULL
.	NULL

Biotechnol	NULL
.	NULL

Appl	NULL
.	NULL

Biochem	NULL
.	NULL

10:6-12	NULL
.	NULL

Davis	NULL
,	NULL
R.	NULL
L.	NULL
,	NULL
and	NULL
H.	NULL
Weintraub	NULL
.	NULL

1992	NULL
.	NULL

Acquisition	NULL
of	NULL
myogenic	NULL
specificity	NULL
by	NULL
replacement	NULL
of	NULL
three	NULL
amino	NULL
acid	NULL
residues	NULL
from	NULL
MyoD	NULL
into	NULL
E12	NULL
.	NULL

Science	NULL
256:1027-1030	NULL
.	NULL

Du	NULL
,	NULL
W.	NULL
,	NULL
and	NULL
T.	NULL
Maniatis	NULL
.	NULL

1994	NULL
.	NULL

The	NULL
high	NULL
mobility	NULL
group	NULL
protein	NULL
HMG	NULL
I	NULL
(	NULL
Y	NULL
)	NULL
can	NULL
stimulate	NULL
or	NULL
inhibit	NULL
DNA	NULL
binding	NULL
of	NULL
distinct	NULL
transcription	NULL
factor	NULL
ATF-2	NULL
isoforms	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
91:11318-11322	NULL
.	NULL

Ellenberger	NULL
,	NULL
T.	NULL
E.	NULL
,	NULL
C.	NULL
J.	NULL
Brandl	NULL
,	NULL
K.	NULL
Struhl	NULL
,	NULL
and	NULL
S.	NULL
C.	NULL
Harrison	NULL
.	NULL

1992	NULL
.	NULL

The	NULL
GCN4	NULL
basic	NULL
region	NULL
leucine	NULL
zipper	NULL
binds	NULL
DNA	NULL
as	NULL
a	NULL
dimer	NULL
of	NULL
uninterrupted	NULL
alpha	NULL
helices	NULL
:	NULL
crystal	NULL
structure	NULL
of	NULL
the	NULL
protein-DNA	NULL
complex	NULL
.	NULL

Cell	NULL
71:1223-1237	NULL
.	NULL

Farrell	NULL
,	NULL
P.	NULL
J.	NULL
,	NULL
D.	NULL
T.	NULL
Rowe	NULL
,	NULL
C.	NULL
M.	NULL
Rooney	NULL
,	NULL
and	NULL
T.	NULL
Kouzarides	NULL
.	NULL

1989	NULL
.	NULL

Epstein-Barr	NULL
virus	NULL
BZLF1	NULL
trans-activator	NULL
specifically	NULL
binds	NULL
to	NULL
a	NULL
consensus	NULL
AP-1	NULL
site	NULL
and	NULL
is	NULL
related	NULL
to	NULL
c-fos	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

8:127-132	NULL
.	NULL

Fixman	NULL
,	NULL
E.	NULL
D.	NULL
,	NULL
G.	NULL
S.	NULL
Hayward	NULL
,	NULL
and	NULL
S.	NULL
D.	NULL
Hayward	NULL
.	NULL

1992.	NULL
frans-Acting	NULL
requirements	NULL
for	NULL
replication	NULL
of	NULL
Epstein-Barr	NULL
virus	NULL
ori-Lyt	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

66:5030-5039	NULL
.	NULL

Flemington	NULL
,	NULL
E.	NULL
,	NULL
and	NULL
S.	NULL
H.	NULL
Speck	NULL
.	NULL

1990	NULL
.	NULL

Autoregulation	NULL
of	NULL
Epstein-Barr	NULL
virus	NULL
putative	NULL
lytic	NULL
switch	NULL
gene	NULL
BZLFL	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

64:1227-1232	NULL
.	NULL

Flemington	NULL
,	NULL
E.	NULL
,	NULL
and	NULL
S.	NULL
H.	NULL
Speck	NULL
.	NULL

1990	NULL
.	NULL

Identification	NULL
of	NULL
phorbol	NULL
ester	NULL
response	NULL
elements	NULL
in	NULL
the	NULL
promoter	NULL
of	NULL
Epstein-Barr	NULL
virus	NULL
putative	NULL
lytic	NULL
switch	NULL
gene	NULL
BZLF1	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

64:1217-1226	NULL
.	NULL

Flemington	NULL
,	NULL
E.	NULL
K.	NULL
,	NULL
A.	NULL
M.	NULL
Borras	NULL
,	NULL
J.	NULL
P.	NULL
Lytle	NULL
,	NULL
and	NULL
S.	NULL
H.	NULL
Speck	NULL
.	NULL

1992	NULL
.	NULL

Characterization	NULL
of	NULL
the	NULL
Epstein-Barr	NULL
virus	NULL
BZLF1	NULL
protein	NULL
transactivation	NULL
do-main	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

66:922-929	NULL
.	NULL

24a.Francis	NULL
,	NULL
A	NULL
.	NULL

Unpublished	NULL
data	NULL
.	NULL

25	NULL
.	NULL

26	NULL
.	NULL

27	NULL
.	NULL

28	NULL
.	NULL

29	NULL
.	NULL

30	NULL
.	NULL

31	NULL
.	NULL

32	NULL
.	NULL

33	NULL
.	NULL

34	NULL
.	NULL

Glover	NULL
,	NULL
J.	NULL
N.	NULL
,	NULL
and	NULL
S.	NULL
C.	NULL
Harrison	NULL
.	NULL

1995	NULL
.	NULL

Crystal	NULL
structure	NULL
of	NULL
the	NULL
het-erodimeric	NULL
bZIP	NULL
transcription	NULL
factor	NULL
c-Fos-c-Jun	NULL
bound	NULL
to	NULL
DNA	NULL
.	NULL

Nature	NULL
373:257-261	NULL
.	NULL

Gutsch	NULL
,	NULL
D.	NULL
E.	NULL
,	NULL
E.	NULL
A.	NULL
Holley-Guthrie	NULL
,	NULL
Q.	NULL
Zhang	NULL
,	NULL
B.	NULL
Stein	NULL
,	NULL
M.	NULL
A.	NULL
Blanar	NULL
,	NULL
A.	NULL
S.	NULL
Baldwin	NULL
,	NULL
and	NULL
S.	NULL
C.	NULL
Kenney	NULL
.	NULL

1994	NULL
.	NULL

The	NULL
bZIP	NULL
transactivator	NULL
of	NULL
Epstein-Barr	NULL
virus	NULL
,	NULL
BZLF1	NULL
,	NULL
functionally	NULL
and	NULL
physically	NULL
interacts	NULL
with	NULL
the	NULL
p65	NULL
subunit	NULL
of	NULL
NF-	NULL
Â«	NULL
B	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

14:1939-1948	NULL
.	NULL

Holley-Guthrie	NULL
,	NULL
E.	NULL
A.	NULL
,	NULL
E.	NULL
B.	NULL
Quinlivan	NULL
,	NULL
E.-C.	NULL
Mar	NULL
,	NULL
and	NULL
S.	NULL
Kenney	NULL
.	NULL

1990	NULL
.	NULL

The	NULL
Epstein-Barr	NULL
virus	NULL
(	NULL
EBV	NULL
)	NULL
BMRF1	NULL
promoter	NULL
for	NULL
early	NULL
antigen	NULL
(	NULL
EA-D	NULL
)	NULL
is	NULL
regulated	NULL
by	NULL
the	NULL
EBV	NULL
transactivators	NULL
,	NULL
BRLF1	NULL
and	NULL
BZLF1	NULL
,	NULL
in	NULL
a	NULL
cell-specific	NULL
manner	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

64:3753-3759	NULL
.	NULL

Kobayashi	NULL
,	NULL
N.	NULL
,	NULL
T.	NULL
G.	NULL
Boyer	NULL
,	NULL
and	NULL
A.	NULL
J.	NULL
Berk	NULL
.	NULL

1995	NULL
.	NULL

A	NULL
class	NULL
of	NULL
activation	NULL
domains	NULL
interacts	NULL
directly	NULL
with	NULL
TFIIA	NULL
and	NULL
stimulates	NULL
TFIIA-TFIID-pro-moter	NULL
complex	NULL
assembly	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

15:6465-6473	NULL
.	NULL

Kolman	NULL
,	NULL
J.	NULL
L.	NULL
,	NULL
N.	NULL
Taylor	NULL
,	NULL
D.	NULL
R.	NULL
Marshak	NULL
,	NULL
and	NULL
G.	NULL
Miller	NULL
.	NULL

1993	NULL
.	NULL

Serine-173	NULL
of	NULL
the	NULL
Epstein-Barr	NULL
virus	NULL
ZEBRA	NULL
protein	NULL
is	NULL
required	NULL
for	NULL
DNA	NULL
binding	NULL
and	NULL
is	NULL
a	NULL
target	NULL
for	NULL
casein	NULL
kinase	NULL
II	NULL
phosphorylation	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
90:10115-10119	NULL
.	NULL

Kolman	NULL
,	NULL
J.	NULL
L.	NULL
,	NULL
N.	NULL
Taylor	NULL
,	NULL
L.	NULL
Gradoville	NULL
,	NULL
J.	NULL
Countryman	NULL
,	NULL
and	NULL
G.	NULL
Miller	NULL
.	NULL

1996	NULL
.	NULL

Comparing	NULL
transcriptional	NULL
activation	NULL
and	NULL
autostimulation	NULL
by	NULL
ZEBRA	NULL
and	NULL
ZEBRA/c-Fos	NULL
chimeras	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

70:1493-1504	NULL
.	NULL

Lieberman	NULL
,	NULL
P.	NULL
M.	NULL
,	NULL
and	NULL
A.	NULL
J.	NULL
Berk	NULL
.	NULL

1990	NULL
.	NULL

In	NULL
vitro	NULL
transcriptional	NULL
activation	NULL
,	NULL
dimerization	NULL
,	NULL
and	NULL
DNA-binding	NULL
specificity	NULL
of	NULL
the	NULL
Epstein-Barr	NULL
virus	NULL
Zta	NULL
protein	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

64:2560-2568	NULL
.	NULL

Lieberman	NULL
,	NULL
P.	NULL
M.	NULL
,	NULL
and	NULL
A.	NULL
J.	NULL
Berk	NULL
.	NULL

1994	NULL
.	NULL

A	NULL
mechanism	NULL
for	NULL
TAFs	NULL
in	NULL
transcriptional	NULL
activation	NULL
:	NULL
activation	NULL
domain	NULL
enhancement	NULL
of	NULL
TFIID-TFIIA-pro-moter	NULL
DNA	NULL
complex	NULL
formation	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

8:995-1006	NULL
.	NULL

Luka	NULL
,	NULL
J.	NULL
,	NULL
B.	NULL
Kallin	NULL
,	NULL
and	NULL
G.	NULL
Klein	NULL
.	NULL

1979	NULL
.	NULL

Induction	NULL
of	NULL
the	NULL
Epstein-Barr	NULL
virus	NULL
(	NULL
EBV	NULL
)	NULL
cycle	NULL
in	NULL
latently	NULL
infected	NULL
cells	NULL
by	NULL
n-butyrate	NULL
.	NULL

Virology	NULL
94:228-231	NULL
.	NULL

Mellinghoff	NULL
,	NULL
L.	NULL
,	NULL
M.	NULL
Daibata	NULL
,	NULL
R.	NULL
E.	NULL
Humphreys	NULL
,	NULL
C.	NULL
Mulder	NULL
,	NULL
K.	NULL
Takada	NULL
,	NULL
and	NULL
T.	NULL
Sairenji	NULL
.	NULL

1991	NULL
.	NULL

Early	NULL
events	NULL
in	NULL
Epstein-Barr	NULL
virus	NULL
genome	NULL
expression	NULL
after	NULL
35	NULL
.	NULL

36	NULL
.	NULL

37	NULL
.	NULL

38	NULL
.	NULL

39	NULL
.	NULL

40	NULL
.	NULL

41	NULL
.	NULL

42	NULL
.	NULL

43	NULL
.	NULL

44	NULL
.	NULL

45	NULL
.	NULL

46	NULL
.	NULL

47	NULL
.	NULL

48	NULL
.	NULL

49	NULL
.	NULL

50	NULL
.	NULL

51	NULL
.	NULL

Z	NULL
(	NULL
S1B6A	NULL
)	NULL
FAILS	NULL
TO	NULL
DISRUPT	NULL
LATENCY	NULL
_	NULL
3061	NULL
activation	NULL
:	NULL
regulation	NULL
by	NULL
second	NULL
messengers	NULL
of	NULL
B	NULL
cell	NULL
activation	NULL
.	NULL

Virology	NULL
185:922-928	NULL
.	NULL

Mikaelian	NULL
,	NULL
I.	NULL
,	NULL
E.	NULL
Manet	NULL
,	NULL
and	NULL
A	NULL
.	NULL

Sergeant	NULL
.	NULL

1993	NULL
.	NULL

The	NULL
bZIP	NULL
motif	NULL
of	NULL
the	NULL
Epstein-Barr	NULL
virus	NULL
(	NULL
EBV	NULL
)	NULL
transcription	NULL
factor	NULL
EB1	NULL
mediates	NULL
a	NULL
direct	NULL
interaction	NULL
with	NULL
TBP	NULL
.	NULL

C.	NULL
R.	NULL
Acad	NULL
.	NULL

Sci	NULL
.	NULL

Ser	NULL
.	NULL

II	NULL
Life	NULL
Sci	NULL
.	NULL

316:1424-1432	NULL
.	NULL

Miller	NULL
,	NULL
G.	NULL
,	NULL
H.	NULL
Himmelfarb	NULL
,	NULL
L.	NULL
Heston	NULL
,	NULL
J.	NULL
Countryman	NULL
,	NULL
L.	NULL
Gradoville	NULL
,	NULL
R.	NULL
Baumann	NULL
,	NULL
T.	NULL
Chi	NULL
,	NULL
and	NULL
M.	NULL
Carey	NULL
.	NULL

1993	NULL
.	NULL

Comparing	NULL
regions	NULL
of	NULL
the	NULL
Epstein-Barr	NULL
virus	NULL
ZEBRA	NULL
protein	NULL
which	NULL
function	NULL
as	NULL
transcriptional	NULL
activating	NULL
sequences	NULL
in	NULL
Saccharomyces	NULL
cerevisiae	NULL
and	NULL
in	NULL
B	NULL
cells	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

67:7472-7481	NULL
.	NULL

Packham	NULL
,	NULL
G.	NULL
,	NULL
A.	NULL
Economou	NULL
,	NULL
C.	NULL
M.	NULL
Rooney	NULL
,	NULL
D.	NULL
T.	NULL
Rowe	NULL
,	NULL
and	NULL
P.	NULL
J.	NULL
Farrell	NULL
.	NULL

1990	NULL
.	NULL

Structure	NULL
and	NULL
function	NULL
of	NULL
the	NULL
Epstein-Barr	NULL
virus	NULL
BZLF1	NULL
protein	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

64:2110-2116	NULL
.	NULL

Pearson	NULL
,	NULL
G.	NULL
R.	NULL
,	NULL
B.	NULL
Vroman	NULL
,	NULL
B	NULL
.	NULL

Chase	NULL
,	NULL
T.	NULL
Sculley	NULL
,	NULL
M.	NULL
Hummel	NULL
,	NULL
and	NULL
E.	NULL
Kieff	NULL
.	NULL

1983	NULL
.	NULL

Identification	NULL
of	NULL
polypeptide	NULL
components	NULL
of	NULL
the	NULL
Epstein-Barr	NULL
virus	NULL
carly	NULL
antigen	NULL
complex	NULL
with	NULL
monoclonal	NULL
antibodies	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

47:193-201	NULL
.	NULL

Quinlivan	NULL
,	NULL
E.	NULL
B.	NULL
,	NULL
E.	NULL
A.	NULL
Holley-Guthrie	NULL
,	NULL
M.	NULL
Norris	NULL
,	NULL
D.	NULL
Gutsch	NULL
,	NULL
S.	NULL
L.	NULL
Bachen-heimer	NULL
,	NULL
and	NULL
S.	NULL
C.	NULL
Kenney	NULL
.	NULL

1993	NULL
.	NULL

Direct	NULL
BRLF1	NULL
binding	NULL
is	NULL
required	NULL
for	NULL
cooperative	NULL
BZLFI/BRLF1	NULL
activation	NULL
of	NULL
the	NULL
Epstein-Barr	NULL
virus	NULL
early	NULL
promoter	NULL
,	NULL
BMRFL	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

21:1999-2007	NULL
.	NULL

Rooney	NULL
,	NULL
C.	NULL
,	NULL
N.	NULL
Taylor	NULL
,	NULL
J.	NULL
Countryman	NULL
,	NULL
H.	NULL
Jenson	NULL
,	NULL
J.	NULL
Kolman	NULL
,	NULL
and	NULL
G.	NULL
Miller	NULL
.	NULL

1988	NULL
.	NULL

Genome	NULL
rearrangements	NULL
activate	NULL
the	NULL
Epstein-Barr	NULL
virus	NULL
gene	NULL
whose	NULL
product	NULL
disrupts	NULL
latency	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
85:9801-9805	NULL
.	NULL

Rooney	NULL
,	NULL
C.	NULL
M.	NULL
,	NULL
D.	NULL
T.	NULL
Rowe	NULL
,	NULL
T.	NULL
Ragot	NULL
,	NULL
and	NULL
P.	NULL
J.	NULL
Farrell	NULL
.	NULL

1989	NULL
.	NULL

The	NULL
spliced	NULL
BZLF1	NULL
gene	NULL
of	NULL
Epstein-Barr	NULL
virus	NULL
(	NULL
EBV	NULL
)	NULL
transactivates	NULL
an	NULL
early	NULL
EBV	NULL
promoter	NULL
and	NULL
induces	NULL
the	NULL
virus	NULL
productive	NULL
cycle	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

63:3109-3116	NULL
.	NULL

Schepers	NULL
,	NULL
A.	NULL
,	NULL
D.	NULL
Pich	NULL
,	NULL
and	NULL
W.	NULL
Hammerschmidt	NULL
.	NULL

1993	NULL
.	NULL

A	NULL
transcription	NULL
factor	NULL
with	NULL
homology	NULL
to	NULL
the	NULL
AP-1	NULL
family	NULL
links	NULL
RNA	NULL
transcription	NULL
and	NULL
DNA	NULL
replication	NULL
in	NULL
the	NULL
lytic	NULL
cycle	NULL
of	NULL
Epstein-Barr	NULL
virus	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

12:3921-3929	NULL
.	NULL

Sinclair	NULL
,	NULL
A.	NULL
J.	NULL
,	NULL
M.	NULL
Brimmell	NULL
,	NULL
F.	NULL
Shanahan	NULL
,	NULL
and	NULL
P.	NULL
J.	NULL
Farrell	NULL
.	NULL

1991	NULL
.	NULL

Pathways	NULL
of	NULL
activation	NULL
of	NULL
the	NULL
Epstein-Barr	NULL
virus	NULL
productive	NULL
cycle	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

65:2237-2244	NULL
.	NULL

Sista	NULL
,	NULL
N.	NULL
D.	NULL
,	NULL
C.	NULL
Barry	NULL
,	NULL
K.	NULL
Sampson	NULL
,	NULL
and	NULL
J.	NULL
Pagano	NULL
.	NULL

1995	NULL
.	NULL

Physical	NULL
and	NULL
functional	NULL
interaction	NULL
of	NULL
the	NULL
Epstein-Barr	NULL
virus	NULL
BZLF1	NULL
transactivator	NULL
with	NULL
the	NULL
retinoic	NULL
acid	NULL
receptors	NULL
RAR	NULL
a	NULL
and	NULL
RXR	NULL
a.	NULL
Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

23:1729-1736	NULL
.	NULL

Taylor	NULL
,	NULL
N.	NULL
,	NULL
J.	NULL
Countryman	NULL
,	NULL
C.	NULL
Rooney	NULL
,	NULL
D.	NULL
Katz	NULL
,	NULL
and	NULL
G.	NULL
Miller	NULL
.	NULL

1989	NULL
.	NULL

Expression	NULL
of	NULL
the	NULL
BZLF1	NULL
latency-disrupting	NULL
gene	NULL
differs	NULL
in	NULL
standard	NULL
and	NULL
defective	NULL
Epstein-Barr	NULL
viruses	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

63:1721-1728	NULL
.	NULL

Taylor	NULL
,	NULL
N.	NULL
,	NULL
E.	NULL
Flemington	NULL
,	NULL
J.	NULL
L.	NULL
Kol	NULL
R.	NULL
P.	NULL
B	NULL
S.	NULL
H.	NULL
Speck	NULL
,	NULL
and	NULL
G.	NULL
Miller	NULL
,	NULL
1991	NULL
.	NULL

ZEBRA	NULL
and	NULL
a	NULL
Fos-GCN4	NULL
chimeric	NULL
protein	NULL
differ	NULL
in	NULL
their	NULL
DNA-binding	NULL
specificities	NULL
for	NULL
sites	NULL
in	NULL
the	NULL
Epstein-Barr	NULL
virus	NULL
BZLF1	NULL
promoter	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

65:4033-4041	NULL
.	NULL

Weintraub	NULL
,	NULL
H.	NULL
,	NULL
V.	NULL
J.	NULL
Dwarki	NULL
,	NULL
I.	NULL
Verma	NULL
,	NULL
R.	NULL
Davis	NULL
,	NULL
S.	NULL
Hollenberg	NULL
,	NULL
L.	NULL
Snider	NULL
,	NULL
A.	NULL
Lassar	NULL
,	NULL
and	NULL
S.	NULL
J.	NULL
Tapscott	NULL
.	NULL

1991	NULL
.	NULL

Muscle-specific	NULL
transcriptional	NULL
activation	NULL
by	NULL
MyoD	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

5:1377-1386	NULL
.	NULL

Woodgett	NULL
,	NULL
J.	NULL
R.	NULL
,	NULL
K.	NULL
L.	NULL
Gould	NULL
,	NULL
and	NULL
T.	NULL
Hunter	NULL
.	NULL

1986	NULL
.	NULL

Substrate	NULL
specificity	NULL
of	NULL
protein	NULL
kinase	NULL
C.	NULL
Use	NULL
of	NULL
synthetic	NULL
peptides	NULL
corresponding	NULL
to	NULL
physiological	NULL
sites	NULL
as	NULL
probes	NULL
for	NULL
substrate	NULL
recognition	NULL
requirements	NULL
.	NULL

Eur	NULL
.	NULL

J.	NULL
Biochem	NULL
.	NULL

161	NULL
:	NULL
177-184	NULL
.	NULL

Zhang	NULL
,	NULL
Q.	NULL
,	NULL
D.	NULL
Gutsch	NULL
,	NULL
and	NULL
S.	NULL
Kenney	NULL
.	NULL

1994	NULL
.	NULL

Functional	NULL
and	NULL
physical	NULL
interaction	NULL
between	NULL
p53	NULL
and	NULL
BZLF1	NULL
:	NULL
implications	NULL
for	NULL
Epstein-Barr	NULL
virus	NULL
latency	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

14:1929-1938	NULL
.	NULL

Zhang	NULL
,	NULL
Q.	NULL
,	NULL
Y.	NULL
Hong	NULL
,	NULL
D.	NULL
Dorsky	NULL
,	NULL
E.	NULL
Holley-Guthrie	NULL
,	NULL
S.	NULL
Zalani	NULL
,	NULL
N.	NULL
A.	NULL
Elshiekh	NULL
,	NULL
A.	NULL
Kiehl	NULL
,	NULL
T.	NULL
Le	NULL
,	NULL
and	NULL
S.	NULL
Kenney	NULL
.	NULL

1996	NULL
.	NULL

Functional	NULL
and	NULL
physical	NULL
interactions	NULL
between	NULL
the	NULL
Epstein-Barr	NULL
virus	NULL
(	NULL
EBV	NULL
)	NULL
proteins	NULL
BZLF1	NULL
and	NULL
BMRF1	NULL
:	NULL
effects	NULL
on	NULL
EBV	NULL
transcription	NULL
and	NULL
lytic	NULL
replication	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

70:5131-5142.	NULL
zur	NULL
Hausen	NULL
,	NULL
H.	NULL
,	NULL
F.	NULL
O'Neil	NULL
,	NULL
and	NULL
U.	NULL
Freese	NULL
.	NULL

1978	NULL
.	NULL

Persisting	NULL
oncogenic	NULL
herpesvirus	NULL
induced	NULL
by	NULL
the	NULL
tumor	NULL
promoter	NULL
TPA	NULL
.	NULL

Nature	NULL
272:373-375	NULL
.	NULL

